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ABSTRACT 
 
 
Pregnancy induced hypertension (PIH) occurring during pregnancy, labour and 
puerperium is a major contributor to the high percentage of maternal morbidity and 
mortality in the Eastern Cape Province, and worldwide. 
In South Africa (SA), PIH is the second most common of all primary causes of maternal 
mortality reported in the triennium from 1999 to 2001. From 1999 to 2001, PIH was the 
cause of 20,7 % (n = 507) of all maternal mortalities in SA (Department of Health 
(DOH), 2001:38). In the light of these statistics and other statistics related to other causes 
of MMR, the National Confidential Committee on Enquiries into Maternal Deaths 
(NCCEMD) developed the National Guidelines for Maternity Care in South Africa, a 
Manual for Clinics, Community Health Centres and District Hospitals. The guidelines 
related to PIH were of particular interest in this study.   
  
A quantitative, descriptive and contextual survey was conducted to determine the 
implementation of the National Guidelines for Maternity Care for the management of 
PIH by the midwife at level-1 clinics in the Eastern Cape, and to make recommendations 
for the management of PIH by midwives at level-1 clinics with the intention of reducing 
maternal mortality and morbidity due to PIH.  The research method comprised a 
retrospective record review of the records of all patients admitted with PIH at a level-3 
hospital who were referred by a midwife from a level-1 clinic. Data were collected by 
means of a researcher-administered data collection tool based on the  
iii 
National Guidelines for Maternity Care in SA for the management of PIH. The researcher 
wished to determine whether the National Guidelines for Maternity Care in SA was being 
implemented for the management of PIH by midwives at level-1 clinics in East London. 
A purposive sample of 290 maternal records of mothers who had been  admitted for PIH 
at level 3 after being referred from level-1 clinics from May 1999 to June 2003 were 
used. Data were analysed using descriptive statistics. Ethical issues were taken into 
consideration. Validity and reliability were ensured.   
In conclusion, given the study findings, the researcher has made recommendations with 
the intention of reducing mortality due to PHI in the Eastern Cape. 
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CHAPTER 1 
 
 
                                                                                                       
OVERVIEW OF THE STUDY 
 
 
 
1.1   INTRODUCTION 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
 
Pregnancy induced hypertension (PIH) is the second most common cause of maternal                                                                                                                          
mortality and morbidity in South Africa (SA) (Department of Health (DOH), 1999:04). 
The report by the National Committee on Confidential Enquiries into Maternal Deaths 
(NCCEMD) has revealed that the mortality rate due to PIH is particularly high in the 
Eastern Cape. Despite the high mortality rate in the Eastern Cape, no deaths due to PIH 
were reported in 1999, though, despite other evidence of mortality due to PIH. This may 
be due to underreporting of maternal deaths (DOH, 1999:14).  
 
This chapter addresses the background to the problem and identifies the problem 
statement for the study. The research question is formulated and the research purpose 
explained; the objectives of the research are stated and the significance of the study 
explained. In addition, the assumptions of the researcher are explained so as to allow the 
readers an understanding of the meaning of the concepts used in the study. Lastly, an  
overview of the methodology followed for the study is provided.   
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1.2    BACKGROUND 
 
Many changes took place in SA following the democratic elections in 1994. These 
changes brought about development of new policies and improvement of service delivery 
to the people. According to the National Health Plan of SA, the high maternal mortality 
rate, especially among the previously disadvantaged, was of great concern. The results of 
studies conducted in1989 revealed that maternal mortality rate was 8 per 100 000 for 
Whites and more than 58 per 100 000 for Africans (African National Congress (ANC), 
1994:29). Emanating from the high maternal mortality among Africans, the Minister of 
Health appointed a National Committee on Confidential Enquiries into Maternal Deaths 
(NCCEMD). The purpose of the NCCEMD is to reduce maternal mortality in SA (DOH, 
1998:1). To enable the functioning of the NCCEMD, mortalities during pregnancy, 
labour and puerperium were made notifiable events in October 1997, in terms of the 
National Policy Act Number 116 of 1990.  
 
The National Health Plan (NHP) was developed together with the Reconstruction and  
Development Programme (RDP). These documents looked at creating one single 
comprehensive, integrated and equitable National Health System (NHS). The National 
Health System represents a single governmental structure dealing with health based on 
national guidelines, standards and priorities accountable to South Africans (ANC, 1994: 
19). Amongst the national priorities identified are maternal and child care, protection of 
the environment, women‟s health and care for the disabled, to mention just a few. In the  
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NHP the government follows the new Primary Health Care (PHC) approach to deliver 
health services. PHC is viewed as central to the provision of comprehensive health care 
and was defined in the Alma Ata Declaration as “the essential health care based on 
practical, scientifically sound and socially acceptable methods and technology made 
universally accessible to individuals and families in the community through their full 
participation and at a cost that the community and country can afford to maintain at every 
stage of their development in the spirit of self-reliance and self-determination” 
(ANC,1994:20). PHC forms an integral part of the country‟s NHS as a central focus, 
while PHC guides the overall social and economic development of the community. PHC 
is viewed as the best possible form of health care for the rich and poor in any society 
(ANC, 1994:21). Primary health care is a concept that is changing the medical culture 
and puts emphasis on community participation, empowerment and inter-sectoral 
collaboration. Rural communities in the EC benefit from the PHC services as there are 
few hospitals in the region and the province is mainly rural. PHC services are rendered by 
midwives and professional nurses with varied expertise. Doctors do visit the PHC facility 
at certain intervals and deal with cases that are beyond the scope of practice of the 
midwife.  
Women who are pregnant, in labour or have delivered utilise these PHC services. The 
utilization of these services requires that midwives should keep abreast with knowledge 
and changes taking place in the health system, to enable them to promote, prevent, cure  
and rehabilitate these women if there are complications. At present, PHC services are  
 
3
open from 07:00 to 16:00 in the Eastern Cape and, in the absence of midwives, pregnant  
women are cared for by traditional birth attendants (TBAs) and village health workers 
(VHW). TBAs and VHWs know how to care for these women and what to do should 
complications arise. Village Health Workers (VHW) are also trained by non-
governmental organisations (NGOs) to care for women during pregnancy, labour and 
puerperium.  
One of the challenges facing midwives at PHC clinics is the death of women during 
pregnancy, labour and puerperium, and one of the significant contributors towards 
maternal death is pregnancy-induced hypertension. „Managing pre-eclampsia remains a 
challenge for physicians and health care services‟ (Perez-Cuevas et al, 2003:6). Between 
1999 and 2001, PIH was responsible for approximately 1 in 3 (34,6 %) of maternal deaths 
in SA (DOH, 1999:5). 
 
In the Eastern Cape, the maternal mortality rate was 5,08 per 100 000 births in1999; 6,42 
per 100 000 births in 2000 and 5,51 per 100 000 births in 2001. Given that the MMR is 
high in the Eastern Cape one of the purposes of the NCCEMD is to make 
recommendations based on the confidential study of maternal deaths. These 
recommendations help in the development of policy guidelines that are implemented so 
as to reduce maternal mortality and morbidity as a result of PIH (DOH, 1998:01). 
According to the 1998 NCCEMD report, one of the factors contributing to the high 
incidence of maternal mortality due to PIH is failure to correctly diagnose and manage 
PIH at the initial assessment at level 1 (DOH, 1998). Evidence provided by the DOH  
4
(1998) is as follows:  
 
“Action taken by the midwife on receiving a patient with clinical features suggestive of 
PIH was inappropriate, as identification of the problem at initial assessment was poorly 
done, and standard protocols were not followed in 22 cases at all levels” ( DOH, 
1998:07). 
“Observations of a patient presenting with clinical features suggestive of PIH were done 
infrequently or incompletely or prolonged abnormal observations were recorded without 
action being taken” (Pattison et al., 2000:367). 
 
In addition, the following problems / missed opportunities were identified by the 
NCCEMD with respect to the midwifery management of PIH (Pattison et al., 2000:71; 
DOH, 1998:5):  
 Misdiagnosed cases of PIH and delays in referring patients with clinical features 
suggestive of PIH; 
 Delays in transporting patients with clinical features suggestive of PIH from level 
1 to either level 2 or 3;  
 Failure to implement standard protocols for the management of PIH such as the 
administration of magnesium sulphate to control the blood pressure in PIH as an  
            emergency and maintenance treatment; 
 Not attending patients who requested assistance from the nurses; not assessing  
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patients daily or not carrying out prescriptions; 
 Lack of availability of blood transfusion and lack of intensive care unit (ICU) 
beds, equipment and trained midwives and patients not attending antenatal clinic 
or patients who delay in seeking help. 
 
1.3   PROBLEM STATEMENT 
 
Pregnancy-induced hypertension is rated as the second most important cause of maternal 
mortality in South Africa. This raises concern as PIH can be diagnosed and managed 
before serious complications arise (DOH, 2000:38). According to the report of the 
NCCEMD 2002, there was a marked increase in the notification of maternal mortalities 
as compared to 1998, but the EC and some other provinces, like Limpopo, were noted as 
under reporting the number of maternal mortalities. The under reporting could be 
attributed to the number of home deliveries, which constituted 25 % of deliveries in the 
EC (DOH,1999:2).  
 
Based on the findings of the NCCEMD, Guidelines for Maternal Care in SA, a Manual 
for Clinics, Health Care Centres and District Hospitals was developed. The National 
Guidelines for Maternity Care for the management of PIH provides for the management 
of different conditions that occur as a result of pregnancy, labour or puerperium.  
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The National Guidelines for Maternity Care for the management of PIH provides 
recommendations such as that all women with PIH should be admitted to hospital and 
managed ccording to the severity of the disease (DOH, 2002:75). Despite the 
development and implementation of the National Guidelines for Maternity Care for the 
management of PIH, PIH remains one of the leading causes of maternal mortality in SA. 
In SA, this increase in MMR is not due to lack of knowledge, but due to the fact that the 
available knowledge is not implemented (DOH, 1998:02).  
The researcher was interested in looking at the independent functions of the registered 
midwife with respect to the implementation of the National Guidelines for Maternity 
Care for the management of PIH at level 1, by asking the questions that follow. 
 
1.4  RESEARCH QUESTION 
 
The study sought to elucidate the following issues pertaining to the independent functions 
of the registered midwife with respect to PIH at level 1: 
 
Are the National Guidelines for Maternity Care for the management of PIH (DOH, 2000) 
being implemented by midwives at level 1 to reduce maternal morbidity and mortality 
due to PIH? 
 
What can be done to reduce the maternal morbidity and mortality due to PIH in the EC? 
 
7
1.5   RESEARCH PURPOSE 
 
The purpose of the study was to determine the extent of the implementation of National 
Guidelines for Maternity Care for the management of PIH by the midwife at level 1 with 
the intention of making recommendations for the midwifery management of PIH at level    
1 to reduce maternal mortality and morbidity due to PIH. 
 
1.6     RESEARCH OBJECTIVES 
 
The purpose of the study was achieved through the following objectives: 
 
 To describe the implementation of National Guidelines for Maternity Care for the 
management of PIH by midwives. 
 To make recommendations for the midwifery management of PIH at level 1. 
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1.7   SIGNIFICANCE OF THE STUDY 
 
The fact that South African women continue to die at this important moment of their 
lives, prompted the justification of the study. Countless women in South Africa are 
admitted to hospital for treatment of pregnancy-induced hypertension and treatment of 
complications related to pregnancy-induced hypertension. Many of these women and / or 
their foetuses or neonates die of complications related to pregnancy-induced hypertension 
(DOH, 2000:6). The researcher has also noted that PIH continues to contribute 
significantly to the maternal mortality in SA, despite the fact that there are national 
guidelines that have been developed to be implemented at all levels of care by midwives  
(DOH, 2000:7).   
Information obtained from the study will be fed back to the policy makers, nurse 
educators and practising midwives in the form of recommendations with a view to 
improving the outcome of maternal service to patients with PIH at level 1.  
 
1.8  RESEARCHER’S ASSUMPTIONS 
  
The researcher describes meta-theoretical, theoretical and methodological assumptions in 
order to provide the conceptual framework for this study.  Assumptions are “basic 
principles that are accepted on faith, or assumed to be true without being verified or 
 proved” (Polit & Hungler, 1995:10). These are statements that are taken for granted or  
considered true, even though they have not been scientifically tested. Sources of 
assumptions include universally accepted truths. Assumptions have an influence in the  
9
implementation of the research process (Burns & Grove, 2001:46). 
  
1.8.1   Meta-theoretical assumptions 
 
Introduction 
 
The researcher includes the meta-theoretical assumptions about the midwife, health, 
patient and environment. 
 
Midwife 
 
 A midwife is a person who, having been admitted to a midwifery educational programme 
recognised in the country in which he / she is located, has completed the prescribed 
course of midwifery studies successfully, and has acquired the requisite qualifications to 
enable registration and / or be legally licensed to practise midwifery. The midwife must 
be able to give the necessary supervision, care and advice to women during pregnancy, 
labour and the period of puerperium, to conduct deliveries on her own and to care for the 
newborn and the infant. The care includes preventive measures, detection of abnormal  
conditions in the mother and child, procurement of medical help and the execution of  
emergency measures in the absence of medical help. She has to provide counselling 
where needed and education of the women and also within the family and the community. 
She may practise in clinics, hospitals, domiciliary conditions, health units or in any other  
10
service (Fraser & Cooper, 2003:5).  
 
The midwife is recognised as a practitioner in her own right and as responsible and 
accountable for her own acts and omissions in South Africa. In terms of the South 
African Nursing Act, No. 50 of 1978, as amended, a midwife must be registered with the 
South African Nursing Council (SANC) to practise midwifery (De Kock & Van der Walt, 
2004:1-4). 
 
 Health 
 
Health in this study has to do with a pregnant, labouring and delivered woman for the 
first 42 days after delivery, who shows neither signs of PIH nor risk factors for PIH. A 
healthy woman is physically, socially, spiritually and mentally sound and does not suffer 
from any disease or infirmity. 
 
Patient 
 
In this study, a patient is a pregnant woman who experiences increased blood pressure,  
that is, a systolic blood pressure of 140 mmhg and above, and a diastolic blood pressure 
of 90 mmhg and above, recorded on at least two occasions, four to six hours apart. The 
woman has oedema of the lower extremities and/or the whole body; the presence of  
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protein in urine, that is, there must be a reading of 1+ or more, using a dipstick. In severe  
cases the woman could experience eclampsia. Such a patient received midwifery Care at 
level 1 and was referred by the midwife or by self-referral to a level-3 health centre for 
further management to prevent maternal mortality or morbidity from PIH. 
 
Environment 
 
The environment is a level-1 health care facility that the pregnant woman attended to 
receive antenatal care until she delivered. The relationship between the midwife and the 
patient should be  that of mutual trust and understanding. In this relationship the patient 
should feel free to inform the midwife of any issues affecting her health or the foetus.  
 
1.8.2  Theoretical assumptions 
 
Theoretical assumptions assign meaning to a variable or a definition and describe the 
activities that are required in order to measure it. The definition should be specific to the  
extent that  other researchers can replicate the study and construct the measurement in the 
same way, based on the definitions (Brink, 1996:95). Operational definitions are 
discussed under theoretical assumptions. 
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1.8.2.1   Operational definitions 
 
Midwife 
 
The midwife in this research is registered with the South African Nursing Council on 
completion of the training period, has met all the necessary requirements for midwifery 
studies and has passed the examinations, practises midwifery legally in SA and is 
working at a level-1 clinic. She provides midwifery care to pregnant women with PIH 
and implements the National Guidelines for maternal care, a manual for clinics, health 
centres and district hospitals for the management of PIH, at level 1. She is a person who 
functions according to the regulations and rules of the SANC and the Nursing Act, No. 50 
of 1978, as amended. 
 
Substandard care 
 
The use of the above term, according to the NCCEMD, does not only fail in clinical care, 
but also some underlying factors which may have contributed to low standard care for the 
patient. This includes actions taken by the patient herself or relatives, which may be 
outside the control of the clinicians. Clinician, in this study, refers to the midwife. It also 
considers shortage of staff, administrative failure in the services and back-up facilities 
like laboratory services, radiology and anaesthetics (DOH, 1999:258).  
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Level-1 hospital 
 
This refers to a district hospital or a community health centre situated in the community 
and providing facilities for general practitioners and midwives. It will be regularly visited 
by specialists from provincial hospitals. Certain specialist services may also be rendered. 
 
Level-2 hospital 
 
The level-2 hospital is a base hospital for a region and serves a number of districts. 
Should a complication arise at level 1, the patient may be referred to level 2.  
 
Level-3 hospital 
 
Level-3 hospitals are central or tertiary hospitals, a facilities with specialised equipment 
for management of very ill or difficult obstetric patients (DOH, 2000:14). 
 
Antepartum haemorrhage 
 
According to Fraser and Cooper (2003:297) and (Nolte, 1998:277), antepartum 
haemorrhage is defined as bleeding from the genital tract in a viable pregnancy after the 
24th or 28th week of pregnancy and before the onset of labour. 
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Intra-uterine death 
 
Intra-uterine death refers to the disappearance of foetal life during pregnancy (Nolte, 
1998:370). 
 
Labour 
 
Labour is the process by which a viable foetus, placenta and membranes are expelled 
from the uterus through into the pelvic or birth canal and through the vaginal orifice 
(Fraser & Cooper, 2003:346).   
 
Postpartum haemorrhage 
 
Postpartum haemorrhage is excessive bleeding from the genital tract at any time 
following the birth of the baby up to six weeks after delivery. Postpartum haemorrhage is 
divided into primary and secondary haemorrhage, depending on the time of bleeding after 
delivery (Fraser & Cooper, 2003:521). 
 
Conception 
 
This is the term signifying the fusion of the ovum and spermatozoon which starts the 
beginning of a new life (De Kock & Van der Walt, 2004:6-2) 
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Pregnancy-induced hypertension 
 
Pregnancy-induced hypertension refers to hypertension developing during pregnancy. 
Hypertension is present if the systolic pressure increases by 30 mmhg and the diastolic 
pressure increases by 15 mmhg or BP > 140/90 mmhg. The elevated BP reading should be 
present on two occasions, six hours apart. In the event of PIH, the increased blood 
pressure will develop after 20 weeks and may be accompanied by proteinuria (Nolte, 
1998:290). 
 
Puerperium  
 
Puerperium is the period of time extending from the end of the third stage of labour to the 
end of the sixth week following delivery (Sellers, 1993:1791). Fraser & Cooper 
(2003:626) define the puerperium as the period starting immediately after delivery of the 
placenta and membranes and continuing for six weeks.  
 
Maternal mortality rate 
 
Maternal mortality rate refers to death of a woman as a result of pregnancy and labour 
and includes the first six weeks or 42 days of the puerperium, expressed per 100 000 
childbirths per time unit (Nolte, 1998:515; De Swiet, 2000:760). According to Cronje and  
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Grobler (2007:708), maternal morality rate, where rate is replaced by ratio, is defined as  
the number of women dying in an area from the conception to six weeks after birth per 
total number of live birth for that area, over a defined period expressed per 100 000 live 
births.  
 
Proteinuria 
 
Proteinuria is an excessive amount of protein in the urine. Normally, urine does not 
contain protein, but a trace of protein in urine is not regarded as abnormal. Proteinuria 
during pregnancy is diagnosed when either of the following is present: 
 
0.3g or more of protein in a 24-hour urine specimen; or 
1+ or more protein as measured with a reagent strip (Theron et al, 2006:3-3). 
 
1.8.3    Methodological assumptions 
 
The scientific approach is a method of acquiring knowledge that is generally more 
reliable than tradition (Polit & Hungler, 1995:9). According to Burns and Grove 
(2001:10), science comprises a coherent body of knowledge which is composed of 
research findings and tested theories for a specific discipline. It is both a process and a 
product. It is the accepted process for obtaining knowledge within a specific field (Burns 
& Grove, 2001:10).  
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This research is presented as scientific as it concerns a quantitative study in which the 
research process was applied. The basis for the study was the 1999 to 2001 triennial 
report of the NCCEMD, in which the prevalence of PIH in the Eastern Cape was reported 
and the experience of the researcher at a tertiary health care facility for women referred 
from level 1 due to PIH. Furthermore, the scientific approach has been applied.  The 
researcher developed a research question, aims and objectives.  Then the researcher 
developed a research design and method that would best answer the research questions.  
Data were analysed by means of descriptive statistics. 
 
 
1.9   OVERVIEW OF THE METHODOLOGY 
 
1.9.1  Research design 
 
A brief overview of the research methodology is provided. The reader may refer to 
Chapter 3 for a detailed description. The aim of the study was achieved through a 
quantitative, descriptive and contextual design. According to De Vos (1998:71), 
quantitative research is formalised and explicitly controlled. The data-collecting tool was 
constructed by the researcher. The researcher collected information step by step regarding 
implementation of National Guidelines for Maternity Care for the management of PIH by 
midwives at level-1 hospitals, prior to referral to level-2 and level-3 hospitals.  
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A descriptive design was used to describe the implementation of National Guidelines for 
Maternity Care for the management of PIH by midwives at level 1. A descriptive study is 
a non-experimental study in which the purpose is to observe, describe and document 
aspects of the situation (Polit et al., 2001:180).  
 
A contextual study is a study that seeks to avoid separation of the components from the 
larger context to which the elements may be related (De Vos, 1998:281). The researcher 
focused the study on the midwives in the Amatole district in the Eastern Cape, in the 
context of maternity care. Maternal health services are provided in urban, rural, peri-
urban and informal settlement areas in this district. The maternal care services are run by 
midwives who function according to their scope of practice. Some of the health care 
facilities do not provide midwifery care; as a result obstetric patients are referred to other 
centres that do provide midwifery services. Patients are referred to levels 2 and 3 
respectively for further management, should they present with serious complications, 
such as PIH. Referrals to level 3 are also received from other districts.  
 
1.9.2   Research method 
 
This was a retrospective study of patients who were referred by a midwife from level-1 
facilities to a level-3 health facility, for the management of PIH. A retrospective study is 
a study in which the researcher examines some phenomenon existing in the present that is 
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 linked to other phenomena occurring in the past. Data were collected from the patients‟  
records, thus the study comprised a retrospective review of records.  A checklist was used 
for each record; this was administered by the researcher. The checklist was a data 
collection tool designed according to the National Guidelines for Maternity Care for the 
management of PIH.  
 
Population is the term for setting boundaries on study units. It also refers to individuals in 
the universe who possess specific characteristics determined by the research (De Vos, 
2001:190). The population consisted of women with PIH referred from level 1 and 
admitted to a level-3 health facility, between May 1999 and June 2003. The population 
was identified from the statistical records of the Frere hospital maternity birth register for 
the period under study. 
 
Sampling and sample selection was done by accessing the records of all women who 
received antenatal care from a midwife at a level-1 health care facility and had an 
antenatal card. The records were accessed according to the filing system of the clerks. 
The criteria for inclusion in and exclusion from the population were set as follows: 
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The following criteria were applied for inclusion: 
 
All patients admitted with PIH referred from level 1 to level 3 and were managed by the 
midwife at level 1. 
Records of patients that were complete, that is, included an antenatal card, midwives‟ and 
doctor‟s records from level 1 and level 3. 
The following details had to appear on the antenatal clinic card: 
 Personal details; 
 Obstetrical history, both past and present; 
 Social history; 
 Gynaecological history; 
 Surgical history; 
 Past and present medical and any medical examination done; 
 All the investigations that were carried out; 
 Prophylactic treatment and treatment given; 
 Observations done at each visit; 
 Plot of the foetal growth and maternal condition. 
 
Some records did not have the antenatal cards but the required information was recorded 
on the maternity case sheet or referral letter; such files were included in the study as the 
patient‟s notes were complete.  
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The following exclusion criteria applied: 
 
Patients admitted to level 3 without having been seen by the midwife at level 1; 
Patients who did not attend antenatal care at a level-1 facility; and 
Patients who were unbooked. 
 
Purposive sampling was applied. A total of 550 records were retrieved initially. After 
looking at the inclusion criteria 290 records fitted the criteria. Some patients included in 
the study did not have antenatal cards, but adequate history of level-1 care was recorded 
in their notes.  
 
Data collection refers to the precise systemic gathering of information relevant to the 
research purpose or the specific objectives, questions or hypothesis of a study (Burns et 
al., 2001:794). Data pertaining to the midwifery implementation of the National 
Guidelines for Maternity Care for the management of PIH at level 1 were collected. Data 
were collected by means of a checklist, please refer to annexure C designed according to 
the objectives and purpose of the study.   
 
Collected data were analysed with the purpose of drawing conclusions and reflecting the 
ideas, interests and theories that led to the inquiry (Babbie, 1995:104), please refer to 
chapter 3 for detailed description. Analysis of data was done with the help of a  
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statistician. Descriptive statistics were used. Validity refers to the degree to which an  
instrument measures what it is supposed to be measuring (Polit et al., 2001:308) and 
content validity concerns how well the instrument represents all the different components 
of the variable to be measured (Brink, 1996:168). 
 
The instrument that was used was developed from the following documents, please refer 
to annexure G: 
 
National Guidelines for Maternity Care for the management of PIH; 
The Maternal Death Assessor Control form developed by NCCEMD; 
The Saving Mothers report on Confidential Enquiries into Maternal Deaths in South 
Africa 1998 and the 1999-2001 executive summaries; 
Essential Drug List (EDL); and 
R2488- Regulations relating to the conditions under which registered midwives and 
enrolled midwives may carry on their profession and R2598- Regulations relating to the 
scope of practice of persons who are registered or enrolled under the Nursing Act, 1978  
from the South African Nursing Council (SANC). 
 
Steps were taken to ensure reliability. Inter-rater reliability was not a concern as the 
researcher administered the instrument without assistance. 
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A pilot study is a trial run of the major study and is conducted with the purpose of 
obtaining information to improve the data collection and determine the feasibility of the 
study (Polit et al.,1995: 34). The pilot study to determine applicability was conducted on 
the records of 10 patients collected from a level-3 hospital. The data obtained from the 
pilot study was not included as changes were made to the data collection tool. 
 
 
1.10 ETHICAL CONSIDERATIONS 
 
An overview of the ethical considerations is provided in this chapter (Chapter 1), while a 
detailed discussion on ethical considerations is presented in Chapter 3. The patients 
whose records that were used were not identified by name but by number.  The rights of 
patients were preserved by maintaining confidentiality while working with the records. 
Nobody besides the researcher had access to patients‟ records: Data were collected by the 
researcher in a separate room to ensure privacy and this room was locked whenever the 
researcher had to go out.  The researcher obtained consent to conduct the study from the 
Ethical Committee of the East London Hospital Complex; the ethical committee of the 
University of Witwatersrand; the postgraduate committee of the Faculty of Health 
Sciences of the University of Witwatersrand and the person in charge of the hospital 
(Frere).  A final report will be written and sent to the relevant units after the research to 
ensure dissemination of the research findings. 
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1.11   STRUCTURE OF RESEARCH REPORT 
 
Chapter 1             -     Overview of the study 
Chapter 2                                          -      Literature review 
Chapter 3                                          -      Methodology 
Chapter 4                                          -      Data analysis and results 
Chapter 5                               -      Conclusion, recommendations 
                                                                 and limitations 
 
1.  12  CONCLUSION 
 
Chapter 1 has provided an overview of the study and the background to the study. The 
problem statement was defined, as well as the researcher‟s assumptions. Operational 
definitions have been explained and a brief overview of the methodology given. The  
different types of hypertension during pregnancy, risk factors of PIH, the 
pathophysiology of PIH and the midwifery intervention according to the National 
Guidelines for Maternity Care for the management of PIH will be explained in detail in 
the following chapter. 
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CHAPTER 2 
 
LITERATURE REVIEW 
 
2.1  INTRODUCTION 
  
An overview of studies that have been conducted on pregnancy induced hypertension 
(PIH) in South Africa and internationally is provided in this chapter. Risk factors or 
predisposing causes of PIH and how the organs of the body are affected by hypertension 
in pregnancy are also explored. Factors to be taken into consideration by the midwife 
during history taking and observations to be made in order to diagnose PIH at level 1 are 
discussed and the medical and nursing management during the antenatal and postpartum 
periods of the patient with PIH is explained. The sources used for the development of the 
data collection tool will be described in detail.  
 
The sources used for the development of the data collection tool included:   
 
National Guidelines for Maternity Care for the management of PIH; 
Saving Mothers report on confidential enquiries into maternal deaths in South Africa  
1999-2001executive summary; 
Essential drug list (EDL); 
South African Nursing Council regulations R2488 and R2598; and 
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Maternal death assessor control form (NCCEMD form). 
 
2.2   DEFINITION OF PREGNANCY INDUCED HYPERTENSION  
 
Pregnancy-induced hypertension (PIH) is defined as hypertension and proteinuria 
developing when the pregnancy reaches more than twenty weeks, during labour, or 
during the puerperium in a previously normotensive woman. According to Panday, 
Mantel and Moodley (2004:387), hypertension was defined as a blood pressure of more 
than 140/90 mmHg taken on two occasions of 4 hours apart, and appearing for the first 
time in pregnancy. Increased blood pressure in pregnancy is divided into six categories. 
 
2.2.1   Categories of hypertension 
 
There are six categories of hypertension; these are as follows (Woods, Theron & 
Greenfield, 2006: 3): 
 
 Chronic hypertension; 
 Gestational hypertension; 
 Pre-eclampsia; 
 Eclampsia;  
 Chronic hypertension with superimposed pre-eclampsia; and 
 Unclassified hypertension and unclassified proteinuric hypertension. 
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Each category of hypertension will be discussed in detail.  
 
2.2.1.1   Chronic hypertension 
 
Chronic hypertension is defined as hypertension before pregnancy or an increase in blood 
pressure of 140/90 mmHg before the gestational age of 20 weeks, persisting up to 6 weeks 
(42 days) after delivery (Fraser & Cooper, 2003:358). Nolte‟s (1998:290) definition 
concurs with this, but further identifies the causes of chronic hypertension as follows: 
 
 Essential or primary hypertension; 
 Secondary hypertension; 
 Renal causes, e.g. Nephritis; and 
 Endocrinal causes, e.g. Cushing‟s syndrome. 
 
2.2.1.2   Gestational hypertension        
  
Gestational hypertension is diagnosed when the woman‟s blood pressure rises above 140/90 
mmHg after resting, on at least two occasions no more than one week apart after the 20th 
week of pregnancy if the woman is known to be normotensive. The development of 
hypertension is without signs of pre-eclampsia. Hypertension that is diagnosed for the 
first time during pregnancy and does not resolve after delivery is also classified as 
gestational hypertension (Fraser & Cooper, 2003:358). 
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2.2.1.3    Pre-eclampsia          
 
Pre-eclampsia involves the development of hypertension and proteinuria after 20 weeks 
of pregnancy. Proteinuria is indicated by presence of protein in urine that is greater than 
1+ on a dipstick, or more than 0.3g/L in a random clean specimen of urine in 24 hours 
(Fraser & Cooper, 2003:358; Nolte, 1998:289). Pre-eclampsia is usually associated with 
trophoblastic diseases of the placenta. In the absence of proteinuria, pre-eclampsia is 
suspected when hypertension is accompanied by other symptoms, like headache, 
abdominal or epigastric pain, blurred vision, or altered biochemistry. According to 
Seonae and Davidge (2001:983) pre-eclampsia is diagnosed by the onset of proteinuria 
and hypertension in the latter half of pregnancy.  
 
2.2.1.4   Eclampsia          
  
Eclampsia is indicated by the onset of convulsions during pregnancy or up to 42 days 
after delivery not caused by other pathological conditions, in a woman with pre-
eclampsia. The condition increases the chances of maternal, foetal and neonatal mortality 
(Fraser & Cooper, 2003:358; Nolte, 1998:290).  Eclampsia is defined by Beischer, 
Mackay and Colditz (1997:214) as grand mal seizures occurring as a result of pregnancy- 
related hypoxia. It is a serious complication because of the high risk to the life of both the  
mother and the foetus. 
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2.2.1.5   Chronic hypertension with superimposed pre-eclampsia     
 
Pre-eclampsia superimposed on chronic hypertension is a condition whereby the blood 
pressure of the pregnant woman is found to be increased by 30 mmHg systolic and 15 
mmHg diastolic pressure in a known hypertensive patient, together with the presence of 
proteinuria or generalised oedema (Nolte, 1998: 290; Fraser & Cooper, 2003:358). 
 
2.2.1.6   Unclassified hypertension and unclassified proteinuric hypertension 
 
Unclassified hypertension and unclassified proteinuric hypertension is diagnosed with 
reference to a patient seen for the first time in the second trimester of pregnancy with 
hypertension and / or proteinuria (Theron et al., 2006: 3-5). 
 
2.3   GRADING OF HYPERTENSION IN PREGNANCY 
 
Hypertension is revealed through a blood pressure of 140/90 mmHg or higher on two 
occasions about six hours apart (DOH, 1998:76). Pregnancy-induced hypertension is 
graded as follows (DOH, 1998:76): 
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Grade Blood pressure Proteinuria Oedema 
Mild 140/90 mmHg or above Nil + 
Moderate 150/100 mmHg or  above + ++ 
Severe 160/110 mmHg or above ++ +++ 
 
 
2.4   INCIDENCE OF HYPERTENSION IN PREGNANCY 
 
Pregnancy-induced hypertension causes complications in 5 to 8 % of all pregnancies in 
South Africa. Pregnancy-induced hypertension complicates 12 % of primigravidae 
pregnancies (Sellers, 1993:1163). 
 
In South Africa, 5 to 10 % of pregnancies were complicated by PIH between 1999 and 
2001 (DOH, 2002:73). According to a study conducted by Buga (1996:22) at the Umtata 
general hospital (UGH) between 1993 and 1994, 42.9 % of pregnancies in primigravidae 
were complicated with PIH. Of these, 4.6 % of patients developed complications of  
hypertension in pregnancy. 
 
In another study, conducted by Mateyise (1996:73), at the Umtata general hospital, PIH 
was identified as the cause of 76,7 % (n = 270) of antenatal pregnancy-related 
complications, and  39.4 % of the 76.7 % of patients developing hypertension also  
developed eclampsia. 
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 2.5   PRECIPITATING FACTORS AND RISK FACTORS 
 
Pregnancy-induced hypertension is common in patients who have had PIH / and pre- 
eclampsia during previous pregnancies, although the severity of the condition decreases  
with subsequent pregnancies. A midwife should be able to identify the risk factors which 
could lead to the development of PIH. Any woman presenting with these factors should 
be seen in the antenatal clinic more often, so as to identify any deviation in blood 
pressure from normal at an early stage, in order to intervene immediately. Pregnancy-
induced hypertension is a worldwide problem (Sellers, 1993:1163; DOH, 2002:74;  
Nolte, 1998 :291; Beischer et al., 1996:209). The risk factors for PIH are identified as 
follows: 
 
Primigravida - Epidemiological studies suggest that there is abnormal placentation caused 
by genetically predetermined maternal immune response to antigens of the foetus derived 
from the father and expressed in normal foetal tissue. The prevalence 
     decreases after long-term exposure to the paternal sperm (Fraser et al., 2006:338). 
 
Multigravida - The risk is as has been described for primigravida but, in the case of 
multigravida, the risk will increase again if the partner is changed. 
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Previous pregnancy complicated by PIH or such a history in the family – A past history 
of a pregnancy complicated by pre-eclampsia that developed during the late second or 
early third trimesters are at risk of developing pre-eclampsia again (Theron, Wood, 
Greenfield, Louw & De Groot, 2006:3-19). 
 
Maternal diseases like hypertension, cardiac, diabetic mellitus or thrombophilia – The 
category falls under conditions associated with micro vascular diseases leading to 
abnormal placentation and reduced placental perfusion (Fraser, Cooper & Nolte, 
2006:339). Insufficient placental perfusion leads to increased production of thromboxane, 
which increases aggregation of platelets causing vasoconstriction (De Kock & Van der 
Walt, 2004:20-4). 
 
Socio-economic status – Poverty will prevent a woman from making regular visits to the 
clinic for antenatal care (Fraser, Cooper & Nolte, 2006:340). 
 
Multiple pregnancy – Due to a large placental mass, there is inhibition of invasion of the 
spiral arteries. This results in decreased placental perfusion, which leads to hypoxia of the 
placenta. Hypoxia leads to the release of thromboxane, which causes platelet aggregation. 
The effect of the aggregation of platelets is vasospasm and increased blood pressure 
(Fraser, Cooper & Nolte, 2006:339). 
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Hydatidiform mole (trophoblastic disease) – the trophoblast invades the spiral arterioles 
in the wall of the uterus. The invasion leads to formation of funnel-shaped vessels that are 
unresponsive to vasoconstriction. The placenta becomes insufficiently perfused and 
thromboxane production is increased. Thromboxane leads to platelet aggregation and 
causes vasoconstriction, thus hypertension (De Kock & Van der Walt, 2004:20-4).  
 
2.6   PATHOPHYSIOLOGY 
 
The pathophysiology of hypertension in pregnancy will be discussed in more detail under 
the following headings: 
 
 Decreased trophoblast infiltration of spiral arterial walls in early pregnancy; 
 Vascular damage with increased endothelial permeability; 
 Thrombocytopenia; 
 Glomerular endotheliosis; 
 An increased sensitivity to vasopressors; 
 Arteriolar spasm with decreased intravascular blood volume; and 
 Prostacyclin-thromboxane balance. 
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2.6.1   Decreased trophoblast infiltration of spiral arterial walls in early pregnancy 
 
Trophoblastic invasion of the spiral arteries of the myometrium and decidua causes the 
arteries to widen, allowing more blood to flow to the intervillous spaces. The process 
starts before the eighth week of pregnancy. In pre-eclampsia, the same process occurs to 
a lesser degree (if it occurs at all), resulting in narrowing of the blood vessels. Narrowing 
of the blood vessels leads to placental insufficiency and poor foetal growth (Cronje & 
Grobler, 2007:499). According to De Kock and Van der Walt (2004:20-4) and Fraser, 
Cooper and Nolte (2006:338), placental insufficiency results in the production of 
thromboxane, which increases the aggregation of platelets and causes vasoconstriction. 
Vasoconstriction eventually leads to hypertension. 
 
2.6.2    Vascular damage with increased endothelial permeability 
 
A capillary leak leads to oedema, fibrin and sub-endothelial platelet deposition, 
haemorrhage and necrosis of vital organs like the brain and liver. The maternal immune, 
vascular integrity maintenance and anticoagulant effects are all complex actions  
modulated by normal vascular endothelial cells. The damaged endothelium loses normal 
functioning and produces pro-coagulant, vasoconstriction substances and mitogens (an 
agent that triggers mitosis) (Cronje & Grobler, 2007:499). The increased permeability of 
 
 
35
the capillaries can result in oedema, protein in the urine and decreased plasma volume  
(De Kock & Van der Walt, 2004:20-4). The endothelial cells regulate the capillary 
transport, control plasma lipid contact and modulate vascular smooth muscle reactivity to 
different stimuli (Fraser, Cooper & Nolte, 2006:339). 
 
2.6.3    Thrombocytopenia 
 
Injury to the endothelium results in increased activation of platelets, platelet consumption 
in the microvasculature and excessive clotting activity. As a result, platelet count 
decreases, damage to erythrocyte increases and abnormal platelet function results (Cronje 
& Grobler, 2007:499). Increased consumption of platelets leads to thrombocytopenia and 
may be responsible for disseminated intravascular coagulation (DIC). Progression of the 
disease could lead to fibrin and platelets occluding blood flow to the placenta, brain, 
kidneys and liver (Fraser, Cooper & Nolte, 2006:339). 
 
2.6.4    Glomerular endotheliosis 
 
A glomerular lesion in the kidney is characterised by glomerular endothelial oedema with 
underlying fibrinoid deposits. Flow of blood to the kidney and the filtration rate of the  
glomerulus are reduced. Permeability for proteins is increased, resulting in proteinuria  
and oliguria (Cronje & Grobler, 2007:499). Renal damage results in reduced creatinine  
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clearance leading to increased creatinine and uric acid levels (Fraser, Cooper & Nolte,  
2006:339). 
 
2.6.5    An increased sensitivity to vasopressors 
 
The transfer of sodium from the extra cellular space to the intracellular space, especially 
in artery walls, is increased, leading to an increased sensitivity to vasopressors. Though 
there is a twofold increase in the activity of renin-angiotensin II, bold pressure in normal 
pregnancy does not rise due to reduced sensitivity to angiotensin II. In pre-eclampsia, 
there is an increase in sensitivity to angiotensin II (Cronje & Grobler, 2007:500; De Kock 
& Van der Walt, 2004:339). 
 
2.6.6    Arteriolar spasm with decreased intravascular blood volume 
 
Plasma colloid pressure is reduced due to leakage of plasma proteins resulting from 
damaged blood vessels. Leakage of plasma proteins leads to an increase in oedema within 
the intracellular space, lungs become congested and pulmonary oedema develops, leading  
to cyanosis as a result of poor oxygenation. Hepatic vascular bed blood vessels constrict,  
leading to oedema and hypoxia of liver cells. Oedema of the liver causes epigastric pain  
and can lead to intracapsular haemorrhages or rupture of the liver. A rise in liver enzymes 
and a fall in serum albumin indicate altered liver function. Haemoconcentration and 
hypovolaemia result from reduced intravascular plasma volume, leading to elevated  
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haematocrit. The combination of dysfunction of the cerebrovascular endothelium and 
hypertension causes the permeability of the blood-brain barrier to increase, resulting in 
oedema of the cerebrum. Cerebral oedema is indicated by severe headaches, convulsions 
and blurred vision. Formation of blood clots, cerebral oedema and cerebral vasospasm 
result from the disrupted auto regulation of the cerebral flow (Fraser, Cooper & Nolte, 
2006:339). According to Cronje and Grobler (2007:500), increased cardiac output, 
systemic vascular resistance, hypertension and haemoconcentration lead to arteriolar 
spasm seen in the fundus of the eye and nail bed as segmental spasm.  
 
2.6.7    Prostacyclin-thromboxane balance 
 
Prostaglandins are synthesised in the utero placental area. In a normal pregnancy, 
prostacyclin is predominant, has a vasodilatory effect and opposes platelet aggregation in 
spiral arteries. In pre-eclampsia, thromboxane is dominant and this results in 
vasoconstriction and aggregation of platelets (Cronje & Grobler, 2007:501).  The definite  
cause of pre-eclampsia is not known; the condition occurs in human pregnancy and  
resolves afterbirth. The placenta is considered to be the primary pathology and the foetus  
is involved to a certain extent. The disease process results in generalised vasoconstriction 
and multi-organ involvement, for example, the central nervous, cardiovascular, hepatic 
and coagulation systems are at risk (De Kock & Van der Walt, 2004:20-4). 
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2.7   DIAGNOSIS 
 
A full history and assessment of a pregnant woman on admission is vital in order to make 
the correct diagnosis of PIH. The diagnosis of PIH requires the presence of proteinuria 
and raised blood pressure, more especially if the pregnancy has reached 20 weeks or 
more , or is accompanied by an increase in mass of more than 0.5 kg per week between 
20 and 30 weeks, or involves a sudden increase in mass of greater or equal to 1 kg per  
week (Cronje & Grobler, 2006:499). After assessment, implementation of the correct  
midwifery management of PIH is done to prevent complications from occurring. The 
following assessment should be conducted by the midwife at level 1 (Fraser & Cooper, 
2003: 365; DOH, 2002:7). 
 
 Severity of the oedema of the lower extremities and/or whole body; 
 Accurate measurement of the blood pressure; 
 Assessment of the presence of vaginal bleeding; 
 Pallor and jaundice; 
 Uterine tenderness and irritability; 
 Liquor volume and foetal size; 
 Assessment of the cervix for ripeness; 
 Urinalysis for the presence of protein; and 
 Assessment of the condition of the foetus using the foetal scope or non-stress test. 
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The midwife should ask about the presence of the following symptoms of imminent 
eclampsia during history taking (Fraser & Cooper, 2003:365; DOH, 2002:7): 
 
 Nausea and vomiting; 
 Drowsiness or confusion due to cerebral oedema; 
 Visual disturbances, that is, flashing lights or blurring of vision due to retinal 
oedema; 
 Epigastric pain denoting liver oedema and impairment of the liver; 
 Persistent frontal headache due to cerebrovascular endothelial dysfunction; 
 Increase in proteinuria due to glomerular endothelial damage; and 
 Reduced urinary output caused by acute vasospasm.                                                                  
 
2.8   PREVENTION OF HYPERTENSION IN PREGNANCY 
 
Pregnancy induced hypertension is a criterion for referral to either level 2 or level 3, 
depending on the severity of the disease. The midwife‟s role is to promote health; prevent  
disease by making a midwifery diagnosis; initiating treatment and to refer promptly 
before complications arise; and to rehabilitate the woman after the disease. The midwife 
has the following responsibilities to ensure that proper care is given to the pregnant 
woman (DOH, 2001:50): 
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 Encourage all pregnant women to attend antenatal care clinics so that screening 
for PIH can be done and abnormal conditions be detected early and to intervene 
promptly;      
 Educate patients on the importance of informing health care providers about the 
past obstetrical history; 
 Explain the need to start antenatal care early, that is, at three months or as soon as 
the woman realizes that she has missed a period because of the possible 
recurrence of PIH; 
 Education should also include the five „danger signs‟ listed below, which should 
be reported to the midwife when attending for antenatal care, or be reported as 
soon as they occur, even if the woman is not due to return to the antenatal clinic. 
o Severe headache; convulsions; blurring of vision; 
 Abdominal pain; 
 Vaginal bleeding; 
 Reduced foetal movements; and 
 Drainage of amniotic fluid from the vagina. 
 Health care providers should be aware of  risk factors for developing hypertension 
or its complications; 
 The health care provider should have knowledge on how to use drugs for the 
management of acute hypertension so as to prevent complications from occurring; 
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 Health care providers should also be alert to the high blood pressure in pregnancy,  
that is, blood pressure of 140/90 mmHg and above, so as to diagnose its onset at the 
earliest possible moment. Blood pressure is expected to drop during pregnancy, 
due to physiological changes in the circulatory system of the mother; 
 Magnesium sulphate must be available at all antenatal care facilities and 
emergency service facilities, and midwives are required to have the required  
             knowledge to administer it; 
 Criteria for referral and referral systems should be known to health providers and 
emergency transport must be available for all pregnant women who experience 
complications at any site.  
 
 
2.9   MANAGEMENT OF THE WOMAN WITH PIH AT LEVEL ONE 
 
When a woman is pregnant, the important factor is for the condition of pregnancy-
induced hypertension (PIH) to be identified as soon as possible, so that effective 
treatment can be initiated as there is no effective method of preventing PIH and the most 
effective treatment of severe PIH is termination of pregnancy (De Kock & Van der Walt,  
2004:20-4). The midwife should diagnose PIH early, refer the woman to the doctor for 
treatment and follow up the woman at the antenatal care centre to reduce maternal 
morbidity and mortality. 
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2.9.1   Management of mild and moderate PIH by the midwife at level 1 
 
Mild PIH is defined as blood pressure of 140/90 mmHg, or a diastolic blood pressure of 
less than a 100 mmHg, according to De Kock and Van der Walt (2004:20-7), no  
proteinuria and oedema+ (DOH, 1998:76). The affected woman should be given the 
following: 
 
 A loading dose of methyldopa 1g orally; and 
 She should be referred to the level-2 hospital on the same day (DOH, 2007:82). 
 
With the management of a woman without proteinuria and other symptoms besides 
elevated BP, when this is less than 160/110 mmHg, the following should be done: 
 
 Advise the woman to rest; 
 Find out about home surroundings and availability of transport; 
 The woman should be reviewed after 2 to 3 days to assess the progress of the  
            condition; 
 If there is doubt about the management, the woman should be referred to hospital 
(DOH, 2006:63); 
 Educate the woman about diet, explain to her not to have extra salt, follow a diet 
that is low in carbohydrates and high in vitamins and proteins; 
 Urine must be tested weekly for the presence of protein in the urine; 
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 Blood  pressure must be measured on a weekly basis; 
 Foetal movements must be monitored daily; 
 The foetal condition must be monitored using a cardiotocograph (CTG) on a 
weekly basis. 
 
According to Fraser, Cooper and Nolte (2006: 342), the following assessment should be 
done at each visit: 
 
 Weigh the woman to assess weight gain to determine excessive weight which 
could indicate oedema. 
 
The woman should be educated about the five pregnancy „danger signs‟ and urged to 
report them to the clinic or hospital, with the antenatal card, as soon as they occur. These 
signs are (DOH, 2002: 24): 
 Severe headache, blurred vision or visual disturbance; 
 Vaginal bleeding; 
 Reduced foetal movements; 
 Abdominal pain; and 
 Drainage of amniotic fluid from the vagina.  
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2.9.1.1      Elaboration of danger signs 
 Severe headache 
 
Severe headache which is persistent and frontal in location is due to cerebral oedema and 
could be indicative of imminent eclampsia (Fraser, Cooper & Nolte, 2006:344). 
    
 Vaginal bleeding 
 
One of the causes of vaginal haemorrhage during pregnancy is premature separation of 
the placenta from the uterine wall while the foetus is still in the uterus. The condition is 
common in pre-eclampsia (Berkow, 1999:1158). Vaginal bleeding could be an indication 
of placenta praevia, lesions of the cervix or vagina and an abruption of the placenta 
(Fraser, Cooper & Nolte, 2006:261). 
 
 Reduced foetal movements 
 
Reduced foetal movements occur in a compromised foetus.  The woman should be 
advised to count foetal movements and not just kicks for an hour at the same time every 
day. If fewer than four movements occur in one hour, the count should be repeated at the 
same time the next day. If the foetal movements are four per hour or fewer after about a 
 week of counting, the counting should be continued for another hour. If still fewer than 
four, the woman should go to the clinic or hospital for an assessment of foetal wellbeing  
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by a cardiotocograph (CTG) machine (DOH, 2002:76). Reduced foetal movements  
indicate foetal distress or compromise. Patterns of foetal movements are a reliable sign of 
foetal wellbeing. The foetus should make at least 10 movements per day; if the foetus is 
taking longer to achieve 10, it could be in danger and the mother must visit the health  
centre (Fraser, Cooper & Nolte, 2006:260). 
 
 Abdominal pain 
 
Abdominal pain is common in pregnancy and is suffered by almost all women. The two 
types of pain are pregnancy specific and incidental, pathological or non pathological. 
Many abnormalities are indicated by abdominal pain, for example, heartburn, excessive 
vomiting, ectopic pregnancy, placental abruption, severe pre-eclampsia and urinary tract 
infection, to mention just a few (Fraser, Cooper & Nolte, 2006:284; De Kock & Van der  
Walt, 2004:26-6; 27-5). 
 
 Drainage of amniotic fluid from the vagina 
 
Drainage of amniotic fluid from the vagina is a sign of premature pre-labour rupture if the 
woman is not in labour. During pregnancy, rupture of membranes is associated with 
cervical incompetence, infection, preterm labour, antepartum haemorrhage, 
malpresentation, cord prolapsed, oligohydramnios and psychosocial problems as a result  
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of hospitalisation for a long time (Fraser, Cooper & Nolte, 2006:302; De Kock & Van der  
Walt, 2004:26-4; DOH, 2002:102). 
 
Rest – as much as possible – is recommended and if the woman does not get enough rest 
at home she may be admitted to hospital to ensure enough rest (Fraser, Cooper & Nolte, 
2006:342; Theron, Woods, Greenfield, Louw & De Groot, 2006:3-23).   
 
 
 2.9.1.2    Special investigations 
 
As recommended by DOH (2007:82), investigation of the following is important: 
 
 Elevated serum urea and creatinine denotes renal damage; 
 Full blood count (FBC) and platelet count. Platelets will be low due to 
disseminated intravascular coagulation (DIC); 
 Increased serum uric acid denotes renal damage; 
 Asparate transaminase (AST) is done in severe pre-eclampsia and eclampsia and 
indicates altered liver function. The investigation is done to have a baseline to 
refer to in the future, as the condition worsens, and to assess the severity of PIH. 
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2.9.2     Management of mild to moderate PIH by the doctor at level 1 
 
As discussed by De Kock and Van der Walt (2004:20-6), the woman should be admitted 
if the following is observed: 
 
 Protein in urine after testing; 
 Development of symptoms of imminent eclampsia; 
 Reduction of foetal movements; 
  Ultrasound scans should be done to assess the volume of liquor amnii due to 
intra-uterine growth restriction; 
 Assess foetal breathing movements or blood flow using Doppler velocimetry to 
determine placental blood flow; 
 Deliver the woman at 38 weeks of pregnancy in the case of suboptimal utero-
placental circulation. 
According to DOH (2001:51; 2002:77), the woman should be given antihypertensives as 
prescribed by the doctor. If she has moderate hypertension, Aldomet 500 mg b.d. orally 
up to a maximum of 750 mg t.d.s. daily should be prescribed. Nifedipine 10 mg is given 
orally three times a day to a maximum of 30 mg if the diastolic BP is > 110 mmHg. A 
maintenance dose of Prazosin 1 mg is given orally three times daily up to a maximum of 
seven mg three times daily should be added.  
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2.9.3      Management of severe PIH and imminent eclampsia at level 1 clinics 
 
The management of severe PIH and imminent eclampsia is the same, as the aim is to 
stabilise the woman‟s condition before she is transferred to either level 2 or 3. The 
dangers that threaten the woman‟s life at this stage are the development of eclampsia or 
intracerebral haemorrhage (Woods et al., 2006:3-28). Severe PIH is defined as an  
increased blood pressure where the diastolic blood pressure is more than 110 mmHg on 
two occasions at least 20 minutes apart (DOH, 2007:82). 
 
2.9.3.1   Management of severe PIH and imminent eclampsia at level 1 by the midwife   
 
According to the guidelines for the management of PIH by midwives at level 1, the 
following is expected (DOH, 2007:82): 
 
 Insert an indwelling Foley‟s catheter to assess the hourly urinary output, and 
ensure that the urine output is not less than 0.5 ml/kg/hour; 
 Measure BP hourly to assess effectiveness of administered drugs; 
 Take blood for AST and LDH to assess liver functioning; urea, creatinine and uric 
acid to assess renal damage; and blood for full blood count (FBC) to assess the 
extent of the damage in the circulatory system including the platelet count; 
 Assess the foetal size and age, using palpation and the CTG for monitoring foetal  
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condition; 
 If gestational age is less than 34 weeks and estimated foetal weight is less than 2 
kg, birth should be delayed, if possible; 
 Give a loading dose of methyldopa 1g orally to lower raised blood pressure; 
 Give Nifedipine 10 mg orally to be swallowed or taken sublingually and not 
chewed; this can be repeated  after 30 minutes; 
 Give magnesium sulphate 4 g diluted with 12 ml normal saline and given slowly 
intravenously over 4 minutes, with 5 g given intramuscularly (IMI) into each 
buttock with 1 ml of lignocaine 1 %. Magnesium sulphate will be continued four-
hourly IMI with 5 g into alternate buttocks with 1 ml of lignocaine 1 %. If the 
patellar reflexes are absent, respiratory rate is less than 16 breaths per minute and 
urinary output less than 0.5 ml/kg/hour, magnesium sulphate should be stopped; 
 Observe for signs of magnesium sulphate toxicity which are absent patellar 
reflexes and a feeling of extreme weakness and decreased respiratory rate. If the 
above signs are present, give calcium gluconate 10 % 10 mls slowly intravenously 
(DOH, 2007:82). 
 After the woman‟s condition has been stabilised, urgent transfer to either level 2 
or 3 should be arranged; 
 
Report signs of imminent eclampsia immediately to the doctor, if present. The signs are: 
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 Pain experienced over the liver; 
 Report of severe headache by the woman; 
 Presence of pulmonary oedema characterised by dyspnoea and cyanosis; 
 Blood pressure of more than 160/110 mmHg despite treatment with the presence 
of 3+ or more protein in urine and severe oedema; 
 Marked oliguria, urinary output less than 30 mls per hour; 
 Presence of the tendency to rub the nose, spots before the eyes or difficulty in 
focusing; all these characterise restlessness, irritability, hyperreflexia and visual 
phenomena (Fraser, Cooper & Nolte, 2006:343); and 
The condition and the importance of referral to hospital should be explained to the 
woman and partner to gain full co-operation. 
 
2.9.3.2   Management of severe PIH and imminent eclampsia by the doctor at level I 
             The following are expected of the doctor at level I: 
 
 If the gestational age is less than 34 weeks or estimated foetal weight less than 2 
kg, steroids, betamethasone 12 mg must be given intramuscularly to the woman to 
enhance foetal lung maturity. After 24 hours a second dose must be administered 
to prevent the danger of hyaline membrane disease. Delay labour for 24 to 48 
hours to allow steroids to take effect; 
 The foetus must be delivered if the clinical assessment or ultrasound foetal size 
indicates more than 34 weeks of pregnancy or the duration of pregnancy not  
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known; 
 If the presentation is abnormal or foetal distress is present, a caesarean section 
should be performed (Woods et al., 2006:3-37); 
 If the gestational age is 26 to 33 weeks or estimated foetal weight is 900 to 1500 g 
and there are no indications for delivery, conservative management should be 
practised, but intra-uterine death due to foetal distress as a result of abruption of 
the placenta should be prevented; and 
 Delivery should take place in hospitals with facilities for managing severe 
eclampsia and very low birth weight babies (DOH, 2007: 82). 
 
 
2.9.4     Maximal safety for the patient during transfer to hospital 
 
The following need to be ensured so as to ensure maximal safety of the patient whilst 
being transferred to hospital: 
 
 The woman should be accompanied by a doctor or midwife to the next level of 
care; 
 Monitoring of both maternal and foetal conditions should continue while being 
transferred in the ambulance; 
 The doctor or midwife accompanying the woman should have the following as 
additional aids: 
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 Magnesium sulphate; 
 Dihydralazine or nifedipine; 
 Calcium gluconate; and 
 Resuscitation equipment. 
If the BP of the woman should rise to 110 mmHg diastolic or more, nifedipine 10 mg or 
dihydralazine 6.25 mg IMI should be given orally.  
If the woman has a convulsion in the ambulance, magnesium sulphate 2 g should be 
administered intravenously over five minutes. The dose may be repeated once only. If 
more than 4 hours have passed after the administration of the loading dose, further 
maintenance doses of magnesium sulphate must be given (Wood et al., 2006:3-30). 
 
2.9.5    Management of the patient with eclampsia by the midwife at level 1 
 
In many cases, the woman is brought to the clinic either having convulsions or with a 
history of convulsions at home for the first time while pregnant. The patient is usually 
either unbooked or not aware of the pregnancy. When such situations prevail, the 
midwife at level 1 is expected to act according to her scope of practice to prevent 
complications to both the mother and foetus. The management should be in accordance 
with the following principles (DOH, 2007:85): 
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 Apply first aid measures; 
 Control convulsions; 
 Prevent further convulsions; 
 Reduce extreme hypertension; 
 Do laboratory and clinical assessment; 
 Expedite delivery; and  
 Practise postpartum care. 
 
The relatives, partner or patient, if conscious after the convulsion, should be informed 
about the condition and reassured to allay anxiety. Emotional support at this time is 
important (Fraser, Cooper & Nolte, 2006:347). 
 
All health care facilities rendering services to pregnant women in SA should have an 
eclamptic box containing equipment for the immediate management of the woman with 
eclampsia. The eclamptic box should contain the following (DOH, 2006:67): 
 
 Magnesium sulphate; 
 Intravenous drip equipment; 
 An indwelling urinary catheter; 
 Calcium gluconate; 
 Aldomet; 
 Appropriate strapping; 
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 Different sizes of syringes; 
 200 ml of normal saline; 
 Venflows or equivalent; 
 Fact sheet on management principles of eclampsia; and  
 Rapid-acting antihypertensive agent.  
 
The midwife should carry out the following actions: 
 Turn the woman onto her left lateral side to improve foetal circulation; 
 Clear the airway and remove secretions, vomitus and dentures and insert an 
airway; 
 Administer 40 litres of 100 % oxygen by face mask to improve oxygenation to the 
foetus; 
 Prevent injuries by using cot sides and removing sharp instruments; and 
 Insert an indwelling urinary catheter to measure urinary output and to obtain a  
specimen for urine analysis. 
 
The woman should be transferred to a tertiary hospital where there is enough equipment 
for further management and personnel to attend to the patient.  Magnesium sulphate 4 g 
diluted with 12 ml normal saline and given slowly intravenously over four minutes, 5 g 
into each buttock, and given with 1 ml of lignocaine 1 %. Thereafter 5 g should be 
administered into alternate buttocks 4-hourly, with 1 ml of lignocaine 1 %.  
55
The following should be checked as precautionary measures before administering the 
magnesium sulphate maintenance dose: 
 
 Patellar reflexes should be present; 
 Urinary output should be 30 mls or more per hour; and 
 Respiratory rate should be 16 b/m and more; if the above signs are abnormal, 
magnesium sulphate should be stopped and the patient should be assessed for 
signs of overdosage; 
 If restlessness and convulsions persist, an additional 2 g magnesium sulphate 
should be given intravenously, or clonazepam 1 g over 5 minutes (DOH, 2007: 
86). The dosage should be repeated once if convulsions continue. 
 Monitor blood pressure and state of consciousness of the woman hourly; and 
 The midwife should notify the doctor or the advanced midwife of any change in 
the woman‟s condition. 
 
2.9.6   Management of the patient with eclampsia after fits have been controlled at level 1 
 
The following is expected of the midwife: 
 
 Monitor blood pressure and state of consciousness of the woman hourly; 
 Control BP if more than 160/110 mmHg by preloading the patient with 200 To 
250 ml Ringer‟s lactate solution over 20 minutes; 
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 A loading dose of methyldopa 1g orally should be given; 
 Administer nifedipine 10 mg orally, to be swallowed; repeat after 30 minutes if 
necessary, but do not give more than 30 mg in 24 hours (DOH, 2007:85; Fraser, 
Cooper & Nolte, 2006:347); 
 Monitor urinary output hourly, as well as respiratory rate; 
 Assess the foetal condition using the cardiotocograph machine and interpret the 
results; 
 Intravenous fluid or Ringer‟s lactate or a normal saline solution should be 
continued at a rate of 80 ml per hour; 
 The baby should be delivered immediately after the convulsions. The midwife 
should do per vaginal examination to assess the dilation of the cervix; if the 
woman is fully dilated, vacuum extraction should be done. Prepare the woman for 
caesarean section if there are signs of foetal distress or the cervix is unfavourable 
for induction of labour.  
 Blood samples for FBC, urea, creatinine, AST and clotting profile should taken 
and sent to the laboratory for analysis; 
 The monitoring will also depend on the state of the patient; 
 Magnesium sulphate should be continued for 24 hours after birth or the last 
convulsion, whichever is last; and  
 The woman should be transferred as soon as possible to a level 2 or 3 hospital 
where there are enough personnel and equipment for further management. 
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2.9.7    Management of the patient with eclampsia by the doctor at level 1 
 
The following is expected of the doctor at level 1: 
 
 If feasible, a central venous pressure line should be inserted to monitor fluid 
volume; 
 Induce labour if the cervix is favourable; and 
 Perform a caesarean section if there is foetal distress or unfavourable cervix or 
obstetrical indication. 
 
2.10     MANAGEMENT OF PIH AT LEVELS TWO AND THREE  
 
2.10.1   Management of the patient with eclampsia at level 2 or 3 by the midwife 
 
According to Nolte (1998:293), if the patient is hospitalised, bed rest and limitation of 
visitors should be instituted. A full history is to be taken, followed by a physical 
examination.  
 
The observations to be made are as follows: 
 Blood pressure, temperature and foetal heart rate should be checked four- to six-
hourly, or more frequently when necessary;  
 The degree of oedema should be assessed twice daily;  
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 The maternal mass must be measured daily so as to assess degree of oedema; 
 The foetus is monitored by doing a twice daily non-stress test and foetal kick 
counts; 
 The urine should be tested for specific gravity, presence of protein and blood 
twice daily; 
 A strict intake and output chart must be kept;  
 Any abnormality noted should be reported to the doctor immediately; 
 The patient should be given a normal balanced diet;  
 Fluid intake need not be restricted; and 
 The woman should be encouraged to count foetal movements daily, as these 
indicate the foetal condition in the uterus and these have to be recorded.  
 
 
2.10.2   Management of the patient with eclampsia at level 2 or 3 by the doctor 
 
The following are expected of the doctor: 
 
 If the gestational age is 28 to 34 weeks, two doses of betamethasone 12 mg should 
be administered intramuscularly, 12 hours apart. This is done so as to stimulate 
lung maturity in the immature foetus. 
 The investigations to be done include a full blood count (FBC); liver function test 
(LFT), serum urea, creatinine and uric acid (24-hour urine specimen).  
59
According to Cooper, Fraser & Nolte (2006:347) anticonvulsant therapy for the 
management of convulsions should be prescribed. The drugs of choice are magnesium 
sulphate, diazepam and phenytoin. Magnesium sulphate is the recommended drug, rather 
than the other two, because it helps in vasodilation, thus reducing cerebral ischaemia. 
Phenytoin is preferred to diazepam as it does not have sedative effects. Magnesium 
sulphate administration is according to the protocol. Antihypertensives are prescribed to  
control increased blood pressure.  
 
Delivery should be considered if the foetal and maternal conditions worsen or if any of 
the following are present (DOH, 2002:76); (DOH, 2001:51): 
 Cerebral oedema; 
 Pregnancy of more than 34 weeks; 
 Pregnancy of more than 32 weeks and severe PIH; 
 Estimated foetal weight of more than 1,5 kg and severe PIH; 
 Foetal distress; 
 Dead foetus; 
 Suspected placenta abruption; 
 Eclampsia; 
 Uncontrollable blood pressure which persistently is more than 160/110 mmHg; 
 Platelet count persistently less than 100 000 unit mm³; 
 Persistently rising uric acid level of more than 0.45 mmol/l; 
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 HELLP syndrome; and 
 Renal dysfunction (urea more than 8 mmol/l, creatinine more than a 100mmol/l 
and urine output of less than 500 ml in 24 hours). 
 
The midwife should be able to assess foetal size by palpation and assess foetal condition 
by means of a non-stress test. The baby should be delivered as soon as possible, so as to 
prevent intra-uterine death and further complications to the mother. 
 
2.10.3   Management of delivery by the midwife 
 
Patients with severe pre-eclampsia and eclampsia often present at a level-1 health care 
facility in established labour. The ideal place for delivery of such patients is a level 3 
health facility, but when labour is inevitable, the midwife will have to conduct labour to 
prevent complications and maternal morbidity and mortality. Care of the woman during 
labour will be described under the stages of labour, which follow: 
 
2.10.3.1   First stage of labour 
 
The midwife should implement the following midwifery management in the first stage of 
labour (DOH, 2001:29):  
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 First seek advice from the referral health care facility and carry out orders;  
 Use a partogram, which is a document that gives information about the patient,  
           maternal and foetal conditions during labour and the progress of labour.  
 Measure blood pressure half hourly, so as to detect abnormalities early;      
 Continue with the maintenance of magnesium sulphate if signs of imminent 
eclampsia are present; 
 Assess foetal heart rate half hourly using a foetal scope before, during and after a 
contraction to exclude decelerations or use the cardiotocograph (CTG) machine; 
 Watch the woman for a change in mental state or alertness, so as to assess for 
central nervous system complications; 
 Give adequate pain relief: the standard narcotic for analgesia in labour is parental 
pethidine 100 mg  with promethazine, intramuscularly, 4-hourly; 
 Intravenous fluids should be given at a rate of 80 ml per hour to prevent 
overloading (DOH, 2007:87). 
 Have emergency treatment in readiness in case resuscitation or further 
management is needed; equipment should be in good working order; 
 Assess progress of labour; if there is a delay, transfer to either level 2 or level 3 
health care facility; 
 Consider transferring the woman if there is poor progress of labour; 
 Progress of labour is monitored at due times, that is, a vaginal examination is 
done 4-hourly, and 2-hourly if there is evidence of foetal distress. Progress of  
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labour is prolonged when cervical dilatation proceeds at a rate of less than 1 cm in  
a primigravida/nullipara and less than 1,5 to 2 cm in gravida two and above 
(Cronje, in Bassin, 1996:57). Contractions are assessed half-hourly, the duration 
and frequency noted and recorded. The normal contraction rate comprises having 
three contractions lasting between 40 and 60 seconds in 10 minutes in the active 
phase of labour. If there is a need for augmentation of labour, fluid should  be 
administered as follows (DOH, 2007: 87): 
 Add oxytocin 5IU to 200 mls Ringer‟s lactate and start infusion at a rate of 5 ml 
per hour. The rate should be doubled as 5, 10, 20, 40, 80 ml/hour every 30 
minutes until three to four strong contractions are achieved. If the desired effect is 
not achieved, a new infusion with oxytocin 10 units in 200 mls Ringer‟s lactate at 
a rate of 40 ml/hr should be started; 
 Descent of the foetal head is described by some authors in fifths above the pelvic 
brim, and is checked abdominally by palpation and confirmed by bimanual per 
vaginal examination (Nel 1995; Cronje, in Bassin, 1996:58). 
 
2.10.3.2   Second stage of labour 
 
The second stage of labour starts at the end of the first stage of labour when there is full  
dilatation of the cervix and ends when the baby is born. The midwife should notify both  
the obstetrician and the paediatrician of the progress of labour. The second stage of  
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labour should be as short as possible, therefore either vacuum or forceps delivery will be  
performed. If the maternal and foetal condition deteriorates during the first stage of 
labour, the doctor, if present, will undertake a caesarean section on the woman. If the 
doctor is not present, the patient will be transferred to level-2 health facility, if birth is not 
possible. The midwife will continue observing the patient and the foetus until delivery 
has taken place. Observation includes the following: 
 
 The midwife should ensure good progress of labour; 
 Measure blood pressure quarter hourly; and 
 Listen to foetal heart after every contraction to assess any decelerations at 15-
minute intervals; 
 Perform vacuum extraction if diastolic BP ≥ 110 mmHg. 
 If a relative or next of kin is present, full explanation of the patient‟s condition should be 
given and such a person must be informed about the patient‟s progress.  
 
After delivery of the anterior shoulder of the neonate, or after the delivery of the neonate, 
the woman is not given syntometrine or ergometrine because both stimulate a sustained  
contraction that will lead to an increase in BP; oxytocin is preferred. Initial administration  
of oxytocin should be 5 units intravenously, followed by 20 units in 200 ml vacoliter to 
be infused slowly (DOH, 2006:65). 
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2.10.3.3   Third stage of labour 
 
The third stage starts immediately after the delivery of the baby and ends when the 
placenta, membranes and the cord are delivered. Active management of the third stage of 
labour will be done to shorten the period of delivery of the placenta, membranes and the 
cord. The third stage will be managed by controlled cord traction. Following birth, the 
woman should be nursed in a high-care unit where antihypertensive treatment will be 
continued for 24 hours. The woman should never be left alone (DOH, 2007:11). 
Midwifery care will continue as follows during the third stage (DOH, 2006: 65):  
 
 Postpartum haemorrhage is prevented or controlled by continuing with the 
oxytocin infusion as indicated above; 
 Magnesium sulphate infusion is continued for 24 hours; 
 The midwife checks the blood pressure immediately after birth, every 30 minutes 
for 4 hours and two-hourly thereafter; 
 Blood pressure should be controlled between 140/90 and 150/100 mmHg; and  
 Urine output should be measured hourly. 
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2.11    MANAGEMENT OF THE WOMAN WITH PIH DURING THE   
           POSTNATAL PERIOD 
 
The puerperium is the period following the delivery of the placenta, the membranes and 
the cord lasting up to six weeks or 42 days after delivery. Serious complications can 
occur during this period; for this reason the woman should be monitored and observed 
very carefully during the puerperium. The midwife should observe the temperature, 
pulse, urine output and blood pressure half hourly, do pad checks for amount, odour, 
consistency and colour of lochia and monitor the contraction of the uterus one hour 
following delivery to exclude postpartum haemorrhage and other abnormalities.  
 
If the blood pressure is elevated during the puerperium, the woman should be transferred 
to a tertiary health care facility for further management. The midwife should arrange 
transport for the patient and accompany her to the hospital. The woman will be admitted 
to a high-care pueperium ward where midwifery care should continue as follows: 
 Observe the woman carefully for the first 24 hours post delivery as there is 
potential danger of eclampsia developing into severe pre-eclampsia (Fraser, 
Cooper & Nolte, 2006:346); 
 Continue with the maintenance dose of MgSo  for 24 hours to prevent 
convulsions (DOH, 2001:30); 
4
 Measure BP immediately after delivery, as it may be affected by the bearing down  
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of the woman and may be low if there is postpartum haemorrhage. Blood pressure  
should be controlled between 140/90 and 150/100 mmHg; 
 Blood for FBC, urea and creatinine should be taken a day following birth to assess 
the progress of the condition; a return to normal is expected (DOH, 2007:86); 
 Advise the woman on contraceptives and suggest the method suitable for her 
condition; if she feels that she has completed her family the midwife may 
motivate for sterilization. 
 On discharge, at least three days after birth, the woman is reminded about 
attending follow-up after one week and then at three weeks, six weeks and twelve 
weeks after birth at the level-3 health care facility. Specific dates should be given 
(DOH, 2006:65). The mother should be reminded to bring the baby along and 
encouraged not to forget the „road to health card‟ (RTHC). 
 The patient should be advised to continue the prescribed antihypertensive drugs 
and to visit her closest level-1 health centre weekly for blood pressure measuring 
and also when she feels that something is wrong with her or the baby (DOH, 
2007:11). 
 Diuretics may be prescribed, if necessary, for example, hydrochlorothiazide 25 
mg orally (DOH, 2007:88). 
 The patient should be encouraged to wear elastic stockings to prevent deep vein 
thrombosis; 
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 The baby should be nursed in a high-care neonatal unit; if the partner is present,  
he can accompany the baby to encourage early bonding. If the mother‟s condition 
permits, she should be wheeled to the nursery to see her baby, or if the condition 
of the baby is satisfactory, the baby may be taken to the mother (Fraser, Cooper & 
Nolte, 2006:348). 
 
2.12   INDICATIONS FOR TERMINATION OF PREGNANCY 
 
Termination of pregnancy refers to purposeful ending of pregnancy to expel the non- 
viable foetus. Viable foetus in South Africa is when the foetus has completed six months 
of gestation, about 24 weeks or 500 g (Cronje & Grobler, 2007: 239). Termination of 
pregnancy is performed for many reasons that will not be discussed in detail in the study. 
Amongst the indications, termination of pregnancy can also be performed where 
continued pregnancy would endanger the life of the woman, pose a risk of injury to the 
foetus and in the presence of severe foetal abnormalities (De Kock & Van der Walt, 
2004:27-2). The indications highlighted below are those which could endanger the life of 
the pregnant woman (DOH, 2006:66): 
 
 Severe hypertension at 34 weeks and more of pregnancy; 
 Uncontrolled hypertension; 
 Intra-uterine growth restriction of the foetus, after consultation with another  
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experienced doctor or midwife; 
 Severe pre-eclampsia that does not respond to expected management prior to 24 
to 26 weeks of gestation; 
 Before 28 weeks, on request of the woman or on doctor‟s advice; 
 Renal failure; 
 Thrombocytopenia associated with pre-eclampsia; 
 Severe eclampsia; or 
 HELLP syndrome, HELLP being the acronym for haemolysis, elevated liver 
enzymes and low platelets. 
 
2.13   COMPLICATIONS AND PROGNOSIS 
 
Complications of hypertension in pregnancy can be divided into maternal and foetal 
complications as hypertension in pregnancy can affect both mother and foetus. 
 
 
2.13.1   Maternal complications 
 
The complications occurring in the mother affect the vital organs in such a manner that, if 
not recognised and treated early, permanent damage could result, leading to either organ  
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dysfunction or the death of the woman: 
 The mother may develop tonic/clonic convulsions if the signs and symptoms of 
imminent eclampsia are not identified and managed; 
 Injuries may be sustained due to convulsions; 
 Stroke can occur due to central nervous system irritability and cerebral damage; 
 Hypertensive encephalopathy can develop in 1 to 2% of cases; 
 Cerebral haemorrhage, which is usually the cause of death, is possible; 
 Hyperthemia; 
 Cortical blindness; 
 Psychosis; 
 Aspiration of stomach contents after vomiting (Mendelson‟s syndrome); 
 Pulmonary oedema; 
 Hepatic failure and jaundice; 
 Renal failure; 
 Placental abruption, a condition characterised by vaginal bleeding due to 
premature separation of the normally situated placenta while the foetus is still in 
the uterus; 
 The woman with PIH can also develop subcapsular hepatic syndrome as a result 
of the reduced hepatic flow, and hepatic haemorrhage because of the oedematous 
swelling of the liver; and disseminated intravascular coagulation is caused by the 
release of thromboplastin; 
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 In severe or uncontrolled cases of PIH, the affected organs exhibit a collection of  
signs and symptoms leading to the condition known as the HELLP syndrome. 
HELLP stands for haemolysis elevated liver enzymes and low platelets (Cronje & 
Grobler, 2006:513; De Kock & Van der Walt, 2004: 20-7). 
 
Maternal complications secondary to hypertension in pregnancy that were identified 
through a study conducted by Buga and Lumu at UGH are presented in Table 2.1 
 
Table 2.1: Maternal complications of hypertension (N = 760) 
 
 
 
 
 
 
 
 
 
 
 
 
 
         
Complications 
% of complications recorded 
from Jan 1993 to Dec 1994 
  
Eclampsia 15 % (n = 114)   
      Abruptio placentae 1.7 %  (n = 13)   
    HELLP syndrome 1.2 %  (n = 9)   
    DIC 0.5 % (n = 4)   
Maternal mortality 1.0 % (n = 8)   
Pulmonary oedema 3.9 % (n = 30)   
Acute renal failure 0.9 %  (n = 7)   
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2.13.2   Foetal complications 
 
According to Mateyise (1996:73, 115), PIH was found to be related to neonatal and 
perinatal mortality. Neonates born to mothers with PIH were more likely to be diagnosed 
with hypoxic ischaemic encephalopathy (HIE), meconium aspiration syndrome (MAS), 
hyaline membrane disease (HMD), stillbirths, intra-uterine hypoxia and neonatal birth 
asphyxia.  
 
The foetuses of mothers suffering from hypertension in pregnancy are more likely to 
suffer from intra-uterine growth restriction and asphyxia neonatorum due to insufficient 
blood flow to the placental bed. Preterm labour is very common in PIH due to 
uncontrolled blood pressure, foetal distress or deterioration in maternal condition, and 
induction of labour or caesarean section will be performed. Prematurity exacerbates the 
perinatal morbidity and mortality rate as the body organs of preterm babies are not 
sufficiently mature (Cronje & Grobler, 2006:506). According to Nolte (1998:23), 
complications attributable to PIH include acute foetal distress or intra-uterine death.  
 
Buga and Luma (1999:219) identified numerous foetal and neonatal complications at the 
Umtata General Hospital in the Eastern Cape between January 1993 and December 1994. 
 These are listed in Table 2.2, below. The complications that developed during the period 
of the research included intra-uterine growth restriction (IUGR), low birth weight (LBW), 
preterm births and neonatal death. Fibrin and platelet aggregation formation in the uterine  
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spiral arterioles lead to reduced blood flow to the foetus, causing foetal hypoxia and  
infarcts.  The amount of oxygen available to the foetus, as well as nutrients, is reduced, 
resulting in IUGR and LBW. Preterm births also result from induced labour when this is 
necessary because the pregnancy endangers the life of both the mother and the foetus. In 
addition, neonatal deaths result from antepartum haemorrhage as a result of abruptio 
placentae (De Kock & Van der Walt, 2004:20-6).     
 
Table 2.2:   Perinatal complications of hypertension.  
 
 
Complications 
No.of complications recorded 
from Jan 1993 to Dec 1994 
% of complications from 
Jan 1993-Dec 1994 
Intra-uterine growth 
restriction 
 
50 
 
6.6 % 
 
Preterm deliveries 
 
257 
 
34 % 
   
Low birth weight 
 
151 
 
19.9 % 
 
Neonatal death 
 
26 
 
3.8 % 
 
Intra-uterine death 
 
85 
 
11.2 % 
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In the United States PIH complicates 6.8 % of pregnancies, is responsible for 15 % of 
maternal mortality and also ranks second to embolic events (Peterson, 1997:1) 
 
2.14   CONCLUSION 
 
The above discussion reflects common issues which arise as a result of PIH. Pregnancy-
induced hypertension (PIH) cannot be prevented, but if the presence of predisposing 
 factors is detected early and diagnosis made immediately, the complications to both the 
mother and the foetus could be prevented. Prompt referral of patients with signs and  
symptoms of PIH to either a secondary or a tertiary health care facility for a second 
opinion should be made without delay. Follow-up of clients suspected of developing PIH 
before and after birth should be done by a midwife. The midwife‟s role is to monitor the 
woman for five to seven days after birth, according to her scope of practice as determined 
by Nursing Council regulation R2488. Where the situation does not allow her to 
discharge the woman after seven days, care must continue until the blood pressure is low, 
oedema subsides and no protein is detected in the urine. 
 
The chapter following this literature review will deal with the methodology followed for 
this research project. 
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CHAPTER 3 
 
METHODOLOGY 
 
3.1 INTRODUCTION 
 
The aim and objectives of the study were achieved through the use of a quantitative, 
descriptive and contextual research design. The research method comprised a 
retrospective review of the records of patients who were referred for further management 
of PIH to a level-3 health care facility by midwives from level-1 health facilities. The 
sample size was 291. The steps followed to collect data, analyse data, interpret the results 
and formulate recommendations are elaborated upon in Chapter 3.  
 
The study was conducted at Frere Hospital. This hospital is a referral and tertiary 
institution in East London. The hospital serves rural, urban, peri-urban and informal 
settlement communities. The hospital is in the Amatole district. 
   
The aim of the study was to determine the implementation of the National Guidelines for 
Maternity Care for the management of PIH by the midwife at level 1,with the intention of 
making recommendations for midwifery management of PIH at level 1 to reduce 
maternal mortality and morbidity due to PIH. 
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3.2    RESEARCH DESIGN 
 
A research design indicates the way the researcher plans and structures the research 
process (Mateyise, 1996:61). Cluett & Bluff (200:19) define a research design as the 
detailed plan of how the research was to be conducted.  The term design is used 
interchangeably with method by some researchers.  The design may be unique to a study 
and well established. 
 
3.2.1   Quantitative design 
 
A quantitative study is a scientific way of acquiring information by working in a 
systematic way. This study is a quantitative study as the researcher scientifically and 
systematically acquired information to full fill the purpose of the study. Information was 
gathered step by step according to a pre-specified plan of action (Polit et al., 2001:13). 
Quantitative research involves collecting data that can be analysed numerically, 
explaining and describing events or characteristics in an objective and numerical manner 
(Cluett & Bluff, 2000:215). According to Brink (1998:5), quantitative research can be 
described as data structured in the form of numbers. For this project, the researcher 
undertook step-by-step collection of information regarding the implementation of 
guidelines for the management of PIH patients at level-1 health care facilities by  
midwives. Data collected was analysed numerically. 
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3.2.2  Descriptive design 
 
The study was descriptive as it was non-experimental and the purpose was to observe, 
describe and document aspects of the situation (Polit et al., 2001:80). The description 
involved the prevalence, incidence, size and measurable attributes of the phenomenon 
(Polit et al., 2001:19). As explained by Burns et al. (2001:248) such a study may be used 
for the purpose of identifying problems with current practices. A descriptive design was 
used to describe the implementation of the National Guidelines for Maternity Care for 
the management of PIH by midwives at level-1 facilities.  
 
Information regarding the demographic data, antenatal care given to women during 
pregnancy, identification of patients at risk and specific midwifery actions taken when the 
patient was found to have an elevated blood pressure were described. 
 
3.2.3   Contextual design 
 
The research design was also contextual. According to Mouton (2002:133), contextual 
design involves the extensive description of the phenomenon in its specific context.  
Maternal care services are provided by midwives who function according to South 
African Nursing Council (SANC) regulations R2488, R2598, R387, R777 and R2418 and 
according to the Nursing Act, 1978 (Act 50 of 1978), as amended. 
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The study was focused on the one hundred and sixty-nine (169) clinics and five (5)  
community health centres in the Amatole District Council. Community health centres 
operate for 24 hours per day and offer maternal care. Out of the 169 clinics, only 30 
provide maternal care. Patients are referred to levels 2 and 3 for further management 
when presenting with serious problems, such as PIH. Referrals to the Frere Hospital 
maternity section are also received from other districts such as U-Khahlamba, Chris Hani 
and O.R. Tambo. 
 
3.3    RESEARCH METHOD 
 
3.3.1 Introduction 
 
A retrospective review of records was done. The records of patients referred by a midwife 
from level 1 to level 3 for further management of PIH were collected for this review. A 
retrospective study is a study in which some phenomenon existing in the present is linked 
to other phenomenon that occurred in the past. The independent variable cannot be 
manipulated (Polit et al., 1995:147). Brink et al. (1998:6) define a retrospective 
 study as the measure of a design that has occurred earlier on.  
 
The retrospective review of records was done to collect data. A checklist was used to 
collect data from the record of each mother referred from the level-1 health care facility  
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by a midwife. This record review was conducted by the researcher. All the records of  
patients who were admitted with PIH and met the criteria for inclusion were reviewed. In 
some instances, antenatal cards were not in the records but information was recorded; if 
the patient had been referred, those records were included in the study.  
 
3.3.2   Population 
 
Population refers to individuals in the universe possessing specific characteristics (De 
Vos, 2001:190). As described by Brink et al. (1996:132), a population is a group of 
objects or persons of interest to the researcher that meet the criteria the researcher is 
interested in studying. The population consisted of all patients admitted with PIH to the 
East London complex, Frere Hospital, from May 1999 to June 2003 whose the records 
were available. The target population comprised all pregnant women diagnosed with PIH 
referred by a midwife at a level-1 health care facility and transferred to a level-3 health 
care facility. Records of patients diagnosed with PIH at level 3 who referred themselves 
to the hospital and were not attending antenatal care at level-1 health care facility were 
not included in the study. 
 
3.3.3. Sample and sampling 
 
A sample is part or fraction of a whole selected by the researcher to participate in the 
research project. A sample consists of selected elements or units from a defined  
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population (Brink, 1996:133). According to Cluett and Bluff (2000:215), a sample is  
defined as the group of individuals selected from a target population as representative of 
that population. The sample for this investigation was identified by means of a labour 
ward register at Frere Hospital. The records of all the patients were retrieved by the 
researcher from where they were kept. The method that was used for sampling was 
purposive, because the chosen records were representative of the topic being studied. It 
consisted only of patients who received midwifery care and were referred via a level-1 
health care facility by a midwife to level 3 upon diagnosis of PIH from May 1999 to June 
2003. 
 
The criteria for inclusion were as follows: 
 
 All patients admitted with PIH referred from level 1 to level 3 and were managed 
by the midwife at level 1. 
 Records of patients that were complete, that is, included an antenatal card, 
midwives‟ and doctor‟s records from level 1 and level 3. 
 
 The following details had to appear on the antenatal clinic card: 
 Personal details; 
 Obstetrical history, both past and present; 
 Social history; 
 Gynaecological history; 
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 Surgical history; 
 Past and present medical and any medical examination done; 
 All the investigations that were carried out; 
 Prophylactic treatment and treatment given; 
 Observations done at each visit; 
 Plot of the foetal growth and maternal condition. 
  
Some records did not have the antenatal cards but the required information was recorded 
on the maternity case sheet or referral letter; such files were included in the study as the 
patient‟s notes were complete.  
 
The following exclusion criteria applied: 
 
Patients admitted to level 3 without having been seen by the midwife at level 1; 
Patients who did not attend antenatal care at a level-1 facility; and 
Patients who were unbooked. 
 
3.3.4    Data collection tool 
 
The research instrument was a checklist which was designed so as to address the aim and 
objectives of the study.  All of the following documents were used to develop a checklist  
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of everything that is expected of the midwife when managing PIH and its complications  
at level 1. 
 
 Maternal Death Assessor Control form designed and used by the NCCEMD; 
 SANC‟s regulations for the practice of midwifery R2488, R2598, R777 and R387 
and the Nursing Act, No 50 of 1978, as amended; 
 Essential Drug List; 
 The Guidelines for Maternal care in SA, a manual for clinics, community health 
centres and district hospitals; 
 Saving mothers second report on Confidential Enquiries into Maternal Deaths in 
SA 1999 - 2001; and 
 Midwifery textbooks.  
 
The data collection tool was a check list. The design of the checklist used to collect data 
will be discussed below. The checklist was designed by the researcher and the following 
categories applied. 
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3.3.4.1  Section A 
 
Demographic data of the patient was collected in section A of the questionnaire. 
Information required included the district the patient came from; date of admission to  
level 3; age of the patient; whether the patient was referred to level 3 or not; if referred, 
from which district? Was the patient transported to level 3? If yes, what was the type of 
transport used? 
 
The information was important in order to determine the area from which the patient 
came, as that would give the researcher an idea of the distance from the health centre and 
availability of transport. In as far as districts were concerned, some have more clinics and 
level-3 hospitals than others. The age of the patient would give the researcher information 
about the group at risk of developing PIH and the parity. Thus the research could address 
the question of whether there was an association between the age and parity of the 
woman to develop PIH. Availability of transport would assist in determining the safety of 
both the mother and foetus en route to level 3 and whether the patient did actually go to 
the referred hospital or not. 
                                                           
3.3.4.2   Section B. 
 
Section B of the checklist required the researcher to collect details about midwifery 
history taking. The section was divided into three sub-sections, as follows: 
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B -1 involved data collection from information pertaining to the antenatal care received 
by the woman at level 1 to identify the risk factors predisposing to PIH. The subsection 
elicited the following important factors: 
 
Whether the woman attended antenatal care or not ( booking status); 
It was established whether the antenatal care card was available as patient‟s previous and 
present history helps the midwife identify the risk factors if they are present. 
Gravidity of the patient, which is the number of times that the patient had been pregnant; 
 Parity, which is defined as the number of viable and live babies delivered by the woman;  
and 
The status of the current pregnancy, whether singleton or multiple pregnancy. 
 
B-2 of the checklist required the researcher to determine whether the midwife recorded 
risk factors for PIH. Risk factors for developing PIH were highlighted in Chapter 2.   
B-3: In section B-3 the researcher was required to establish whether the midwife wrote 
the five danger signs in pregnancy on the antenatal card. The following danger signs were 
expected to have been recorded on the antenatal card as part of health education given to 
the patient during the antenatal period: 
 
 Severe headache; blurring of vision; increasing oedema and convulsions and / or 
coma; 
 Abdominal pain; 
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 Vaginal bleeding; 
 Reduced foetal movements; and 
 Spontaneous rupture of membranes. 
 
3.3.4.3   Section C 
 
In section C the researcher examined the midwife‟s ability to diagnose PIH at level 1. 
Section C was subdivided into subsections.  
 
C-1   The researcher assessed the midwife‟s ability to diagnose PIH. The diagnosis would 
have been made on the following basis: 
 
 Increase in blood pressure on two or more occasions  at least 2-4 hours apart 
(DOH,2007:77); 
 Increase in diastolic blood pressure by 15mmHg and systolic blood pressure by 
25mmHg from pre-conception, more especially if the pregnancy has reached 20 
weeks or more, or is accompanied by increase in mass of more than 0,5 kg per 
week or involves a sudden increase in mass of greater or equal to 1 kg per week 
(Cronje & Grobler, 2007: 498-499);       
 Presence of protein when testing the urine of the woman (Cronje & Grobler, 
2007: 499). 
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C-2  Required the researcher to evaluate whether the midwife detected secondary signs   
        and symptoms of imminent eclampsia.     
 
3.3.4.4   Section D 
 
Section D required the researcher to describe the management of the woman with PIH at 
level 1. Section D was divided into subsections. 
 
D-1 The researcher established whether the blood pressure at level 1 was < 160/110 
mmHg, with no oedema, no proteinuria, no secondary signs and symptoms present. A yes 
or no answer block was provided for the response. 
 
D-1.1  The researcher established the following: 
 
Was the patient admitted or referred? 
Was the patient started on antihypertensives? 
Was the patient reviewed 2 to 3 days later at level 1 to assess the blood pressure? 
 
The expected response was either a yes or a no answer. 
 
D-2 The researcher established factors regarding the following: 
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Whether the blood pressure was > 160/110 mmHg or not at level 1; 
Whether proteinuria, oedema or secondary signs and symptoms were present or not at 
level 1. 
 
D-3 The researcher established whether the patient developed eclampsia at level l or not, 
and, if so, D-3.1 focused on the management of the patient with eclampsia at level 1. 
 
3.3.4.5   Section E 
 
In section E the researcher was required to determine whether the referral procedure of 
the patient with PIH from level 1 to level 3 was adhered to. Section E was subdivided 
into the following subsections. 
 
E-1.1   The researcher determined whether the referral criteria were present at level 1.   
            The referral criteria listed as: 
 Prematurity; 
 Antepartum haemorrhage or abruption placenta; 
 Lung oedema marked by dyspnoea; 
 Underlying cardiac disease; 
 Signs of poor coagulation; 
 Prolonged coma or semi-comatosed or other central nervous system damage; 
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 Renal failure marked by urine output of less than 500ml in 24 hours 
(DOH,2007:83). 
E-1.2   The researcher established whether or not the patient was transferred from level 1-  
             3. 
E-1.3   The researcher established whether criteria for transporting the patient were met.   
 
All the subsections required a yes or a no answer. Spaces for the researchers comments 
were provided. In emergency cases where the patient diagnosed with PIH arrived at level 
1 at an advanced stage of labour, delivery would be allowed to continue if it was too late 
to refer the patient to the level-3 health facility. Delivery of the patient diagnosed with 
PIH would also be allowed to continue at level 1 if transport for a transfer was not 
available or delayed. Under normal circumstance, all patients diagnosed with PIH are 
referred to level-3 health care facilities for further management by the doctor; delivery 
should take place at the hospital.   
                       
Please refer to Annexure C for the data collection tool. 
 
3.3.5 Data collection process 
 
Data collection is the precise systematic gathering of information relevant to the research 
purpose or the specific objectives, questions or hypothesis of a study (Burns et al., 
2001:794).  Approval for using the patients‟ records was obtained from the Hospital  
management and the Ethics Committee of the East London hospital complex. No physical  
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presence of the patients was required, only the records. The researcher used a room for 
keeping of records to collect data. There was co-operation between the personnel of the 
hospital and help was obtained in accessing the records. The environment was conducive 
to data collection as it was seldom used and there was quietness that contributed to the  
researcher concentrating on data collection without being disturbed.  
 
Data were collected by means of the above-mentioned checklist designed according to 
the objectives and purpose of the study. Data were collected by the researcher using one 
data collection tool for reviewing each record. Data collection commenced in the last two 
weeks of November 2003 and continued to mid December 2003 and included the whole 
month of February 2004. Initially, it took the researcher 45 minutes to complete a 
checklist, but as data collection continued, the pace improved to 15 minutes to review the 
record.  
 
 3.4     DATA ANALYSIS 
 
Data analysis involves the manipulation of collected data for the purpose of drawing 
conclusions and reflecting on the ideas, interests and theories that led to the inquiry 
(Babbie, 1995:104). Quantitative data is analysed using statistical procedures which 
cover a broad range of techniques (Polit et al., 1995:36). Analysis was done with the help 
of a statistician. Raw data arranged in the form of a spreadsheet and saved on a compact  
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disc was given to a statistician for analysis. The statistician used a computer to analyse 
the raw data programme and statistical tests used. Descriptive statistics were used to  
summarise and describe data. After the results were tallied, data was presented in the  
form of frequency distribution data; interval data; nominal data; measures of central 
tendency where a mean was used; and simple statistics in the form of percentages (Brink, 
1996:178). 
 
 
3.5     PILOT STUDY 
 
 
A pilot study is a trial run of the major study with the purpose of obtaining information to  
 
improve the research or assess its feasibility (Polit et al., 1995: 34). The actual  
 
conducting of the study on a small scale of 10 patients‟ records was done at the level-3  
 
hospital to test applicability of the data collection tool. The data collection tool had to be  
 
adjusted after the pilot study. Following the pilot study, Section D-4 (Did the patient  
 
deliver at level 1?) was excluded because the 10 records used all showed that patients  
 
were referred to level 3 for further management. 
 
 
 
3.6   VALIDITY AND RELIABILITY 
 
 
Validity is the degree to which the instrument measures what it is supposed to be  
 
measuring (Polit et al., 2001; 308).  
 
Content validity concerns how well the instrument represents all the different components  
 
of the variable to be measured (Brink, 1996:168). In order to ensure content validity, the  
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researcher used all available  and accessible documents discussing the midwifery  
 
management of the patient with PIH at level 1 to design the tool. Literature review was 
 
done, after which essential aspects of the variables were included in the content of the  
 
data collection tool. 
 
 
 The data collection tool was then given to a group of midwives for their opinion on  
 
whether to include or exclude any information and to add whatever needed to be included  
 
in the tool, but was not asked by the researcher. 
 
Predictive validity involves comparing the results of the research instrument obtained  
 
from a particular group of people to some event expected to occur within that population 
in the future (Brink, 1996:169). Predictive validity was used when the instrument was 
designed to categorise pregnant women with PIH according to age. Results obtained from 
this would enable the researcher to predict which age group is more likely to develop PIH 
in future. 
 
Reliability refers to the consistency with which an instrument measures the attribute 
(Polit et al., 2001:305). According to Mouton, reliability concerns whether a particular 
technique, applied repeatedly to the same object, would yield the same result each time 
(Mouton et al., 2002:119). Reliability, however, does not ensure accuracy any more than 
precision does (Mouton et al., 2002:120).  
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The underlying issue is whether the process of the study is consistent, reasonably stable 
over time and across researchers (Burns et al., 2001:305). The instrument was 
administered by the researcher for consistency. The data collection tool was designed to 
collect all the required information from each patient‟s record. 
 
3.7     ETHICAL CONSIDERATIONS 
 
A detailed description of the ethical considerations implemented in this study is provided. 
The rights of patients were preserved as follows: 
 
Anonymity was maintained throughout the research as information collected was not 
identified according to the patients‟ name; numbers were used instead, in case records 
needed to be re-examined. The numbers were arbitrarily assigned and were not patient 
reference numbers. The data and the patient files were kept at a safe location. 
 
Confidentiality was maintained by not identifying the patients‟ records, which were 
handled by the researcher only during data collection. 
 
The researcher maintained privacy during data collection by occupying a private room; 
no other person had access to the patients‟ records.  The researcher locked the room when 
she had to go out. On completion of the data collection process the records were returned 
to the archieves. 
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Justice was observed by obtaining consent for assessing patients‟ records from the person  
in charge of the East London Hospital Complex, refer to annexure D3 and D4. 
Permission was also obtained from the ethical committee of the University (committee  
for research on human subjects (medical)) for clearance of research involving human 
subjects, or patient records, from the postgraduate committee of the Faculty of Health 
Sciences of the University of Witwatersrand; the clearance number is 31. 
 
Non-maleficence was ensured: no harm was done to either the patient‟s name or records.  
The complete and undamaged records were returned to the registry department for 
storage and safe keeping. 
 
Beneficence: This implies doing good or in a given situation balancing benefits against 
harms. It involves positive action on one person‟s part to benefit another person (Fraser, 
Cooper & Nolte, 2006:52). The researcher was good at balancing the benefits of the 
research against the harm of lack of confidentiality. No person other than the researcher 
was exposed to the patient‟s records.  
 
3.8      CONCLUSION 
 
The research design used for this research was quantitative, descriptive and contextual.  
The research method took the form of a retrospective review of records with the use of a  
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data collection tool designed as a checklist.  The population consisted of the records of all 
patients admitted with PIH to Frere Hospital in East London.  Purposive sampling was 
 done for patients who received midwifery care for PIH at level-I health care facilities.  
For simplicity, the data collection tool was divided into five sections, namely: A, B, C, D 
and E. The foci of these subsections were as follows:   
 
Section A - Demographic data of the patient 
Section B - History taking of a pregnant woman. 
Section C - Ability of the midwife to diagnose PIH. 
Section D - Management of the woman with PIH 
Section E - Referral procedure from level 1- to either level-2 or -3 health care facilities. 
 
Analysis of data was done with the help of a statistician and descriptive statistics were 
used.  A pilot study was done before the actual research process.  Validity and reliability 
was maintained and data collection was done by the researcher. Ethical principles of 
beneficence, non-maleficence, justice and rights were adhered to.  
 
 
 
 
 
94
CHAPTER 4  
 
DATA ANALYSIS, RESULTS AND DISCUSSION 
 
4.1   INTRODUCTION 
 
This chapter presents a detailed discussion of the findings about the implementation of 
the National Guidelines for the Management of Pregnancy-Induced Hypertension by 
midwives at level-1 clinics in the Eastern Cape. The population used for this study 
consisted of all patients admitted with PIH to the East London hospital complex of the 
Frere Hospital from May 1999 to June 2001. The sample that was used consisted of 
records of all patients with PIH who were referred from level-1 clinics by the midwife to 
a tertiary hospital for further management by a doctor. The sample size comprised 291 
records. The study was categorised as quantitative, descriptive and contextual. The 
research method used was a retrospective record review study of those patients who were 
referred by a midwife from a level-1 health facility to a level-3 health facility upon a 
diagnosis of PIH. Data collection was done by the researcher using a checklist to study 
the records of all patients referred by a midwife. 
 
The research instrument, namely the above-mentioned checklist, was designed so as to  
address the aim and objectives of the study. The following documents were used to  
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develop a checklist of what is expected of the midwife when managing PIH and its 
complications at level 1:- 
 
 Maternal Death Assessor Control form designed and used by the NCCEMD; 
 SANC‟s regulations for midwifery practice R2488, R2598, R777 and R387 and 
the Nursing Act, No. 50 of 1978, as amended; 
 Essential Drug List; 
 The Guidelines for Maternal care in SA, a manual for clinics, community health 
centres and district hospitals; 
 Saving Mothers second report on Confidential Enquiries into Maternal Deaths in 
SA 1999 -2001; and 
 Midwifery textbooks. 
 
The results for sections A to E are presented. 
 
 
4.2   DEMOGRAPHICS OF THE PARTICIPANTS – SECTION A  
 
The demographics of the participants in the study are described and include the 
following: the districts from which the patient came, age, whether referred or not and  
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transport. The patients referred from level-1 health centres to the tertiary health care  
hospital came from five (5) districts of the Eastern Cape. The districts have secondary 
hospitals which were unable to perform surgery due to non availability of an anaesthetist 
and lack of laboratory health services for further investigations.   
      
4.2.1  Region / District    
 
The Eastern Cape Province is divided into six (6) areas: five districts and one 
metropolitan area.  
Each district has sub-local authorities who have control over health care facilities ranging 
from primary health care to tertiary health care facilities. Refer to Table 4.1 for the five 
districts of the Eastern Cape Province.  The East London complex is in the Amatole 
district; hence the attendance was high for the period under review. Alfred Nzo, Chris 
Hani, O.R. Tambo and Ukhahlamba have one tertiary facility, the Umtata General 
Hospital, and an academic hospital, Nelson Mandela, to which patients from those 
districts were referred. Occasional patients attended tertiary hospitals in other districts 
when this was a patient preference.   
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Table 4.1: Districts that referred patients with PIH to the East London level-3 facility 
during May 1999 to June 2003 
 
District Frequency of patient referrals Percentage (%) 
Alfred Nzo 1 0.34 
Amatole 270 92.78 
Chris Hani 13 4.46 
O.R.Tambo 1 0.34 
U-Khahlamba 6 2.06 
Total 291 100.00 
  
4.2.2  Age 
 
According to the English Oxford Dictionary, age is defined as the period of time that a 
person has lived, the period of existence. Table 4.2 displays the ages of pregnant women 
who attended antenatal care at level-1 clinics and were then referred to level-3 hospitals 
for further management of their PIH. The reproductive age, according to the South 
African National Maternal guidelines, is 15 to 49 years (DOH, 2001: 2). Figure 4.2  
shows the frequency and percentage of the age distribution of women with PIH 
investigated in this study. 
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Table 4.2:  Frequency of the age distribution. 
 
Age 
 
Frequency 
14 – 19 32 
20 – 24 65 
25 – 29 85 
30 – 34 69 
35 – 39 30 
40 – 44 9 
45 – 49 1 
Total 291 
 
The youngest woman referred from a level-1 to a level-3 health care facility was 14 years 
old and the oldest was 46 (SD = 6.14). The mean age was 27.4. Women from 30 years 
and older constituted 37.45 % (n = 109) and those women younger than 30 years made up 
62.54 % (n = 182). Teenagers, calculated from the age of 14 to 19 years, constituted 10.9 
% (n = 32) of all women. In chapter two, teenage pregnancy was identified as one of the 
risk factors for PIH because of the age less than 18 years (Fraser & Cooper; 2003:257).  
 
4.2.3   Referrals 
 
 According to the English Oxford Dictionary, „to refer‟ means „to hand over for 
consideration‟. Referral of patients in this study was from a level-1 health care facility to 
a tertiary hospital in order to hand over the patient to the doctor for further management 
of her PIH. From the total of 291 reviewed records, referred cases constituted 83.16 % (n  
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= 242). The patients who referred themselves to the tertiary hospital made up 16.84 % (n  
= 49). The patients (n = 49) who referred themselves to the tertiary hospital had attended 
antenatal care at level 1, but the signs and symptoms of PIH were not identified by the 
midwife. 
 
The women referred themselves to the tertiary hospital for the following reasons: no 
foetal movements were felt by the mother; onset of labour pains; epigastric pain; per 
vaginal bleeding; blurred vision or convulsions. The referred women were mainly from 
primary health care clinics, day hospitals or health care centres in the Amatole district, 
which has one hundred and sixty-nine (169) clinics in total. 
Table 4.3 indicates the number of patients referred from level 1 to level 3 (Frere hospital). 
Only health care centres referring more than 10 patients were captured.   
 
Table 4.3:  Referred pregnant women from level 1 to the tertiary hospital for the period 
May 1999 to June 2003 
 
Health Care Centre Frequency Percentage (%) 
Braelyn 18   6.19 
Central 23   7.9 
Gompo 34 11.64 
Pefferville 16   5.5 
  Total    91 31.23 
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It was noted that some women who were referred for raised blood pressure, proteinuria or  
having oedema and diagnosed as PIH did not have transport arranged for them at the 
level-1 health care facility. The researcher is of the opinion that women who were 
referred from the level-1 to the level-3 health care facility without having transport 
arranged for them, went back to their homes. The researcher thus suspects that the 
women who were not provided with transport from the level-1 to the level-3 health care 
facility, either experienced convulsions, per vaginal bleeding, intra-uterine death or felt 
no foetal movements in the night. However, the researcher needs to support this with 
evidence from a subsequent study. 
 
Out of the total of 291 patients, 0.34 % (n = 1) presented at level 1 with a BP of 190/130 
mmHg, oedema 2+ and proteinuria 2+. This patient was diagnosed with severe PIH and 
were listed for immediate referral to the tertiary hospital. When a patient preferred to go 
to the tertiary hospital the following day, the dangers of not going on the very same day 
were explained and this was documented in the patient‟s file. The patient was referred 
because she showed signs of severe PIH which needed further management by the doctor 
at the tertiary institution to prevent complications from occurring. Immediate referral of 
women with severe PIH is important to prevent organ dysfunction; abruption of the 
placenta; foetal death; coagulation dysfunction; and, most of all, death due to cerebral 
haemorrhage (DOH, 2007:82).  
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4.2.4   Transport 
 
According to the recommendations of the NCCEMD, emergency transport should be 
available 24 hours a day for immediate referral of patients from home to a health facility 
and between institutions. The ambulances should be well equipped to allow for 
monitoring of the woman and foetus during transportation and to conduct delivery if 
necessary. A midwife or doctor or qualified paramedic should accompany the patient and 
monitoring should continue en route to the hospital (DOH, 2007:17). 
 
The following subsection looks at the different types of transport used by patients when 
being transferred from a level-1 health facility to the tertiary hospital. The role of the 
midwife is to provide antenatal care to the pregnant woman and to refer her to the tertiary 
hospital when signs and symptoms of PIH are identified.  Arranging transport when 
referring the patient to the tertiary hospital for further management by the doctor, to 
prevent maternal morbidity and mortality, is one of the functions of the midwife. 
 
The researcher coded the transport used by the patient as follows: 
 
 Private / own; 
 Ambulance; 
 Unknown; and  
 Public. 
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The codes are explained further as follows: 
1 – Private/own car signifies a woman who had her own transport from home to the 
health care centre or hospital. 
2 – Ambulance in this study refers to vehicles owned by the government for free use by a 
pregnant woman. Patients were conveyed from either a level-1 health care centre or from 
 home to the tertiary hospital for further management of PIH. All ambulances are 
supposed to have two health care providers, known as paramedics and trained to deal 
with an emergency and maternal care, either on the scene or en route to the hospital. As 
the paramedics were two to an ambulance, one drove the ambulance and the second one 
would be attending to the patient in the back of the ambulance.  
3 – Unknown indicates that no type of transport was identified and no copy of the record 
usually left by ambulance attendants was available to identify how the woman came to 
the hospital, or whether she walked to the hospital. 
4 – Public transport refers to either a taxi or a bus, hired or boarded by the woman from 
home, a taxi rank or a bus stop to the hospital. These, as public transport facilities, 
conveyed passengers from one point to the next with intermittent stoppages for 
passengers to alight at their destinations. 
 
Table 4.4 illustrates the modes of transport used by patients, either from home or from the 
level-1 health care facility to the tertiary hospital.  
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Table 4.4:  Transportation of patients from level-1 clinics to the tertiary hospital 
(frequency and percentage). 
 
Transport Frequency Percentage (%) 
Private    17  5.84 
Ambulance    97 33.33 
Unknown  162 55.67 
Public   15   0.15 
Total  291 100.00 
 
According to the collected data, 5.15 % (n = 15) of patients with PIH hired public 
transport to the tertiary hospital; these patients were at risk because there were no 
paramedics or health care providers to provide care if complications arose along the way. 
Out of 242 referred patients, the mode of transport use to get to the tertiary hospital of 
55.67 % (n = 162) of patients was not known and the practice of not arranging safe 
transport could have been detrimental to the patients as this category constituted more 
than 50 % of those referred. According to the policy and management guidelines 
reflecting common causes of maternal deaths, a patient should be transferred safely to the 
appropriate institution for further management (DOH, 2001:1). The National Committee 
on Confidential Enquiries into Maternal Deaths (NCCEMD) in SA included ten key 
recommendations after their first report. In the executive summary, recommendation  
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Number 3 clearly states that emergency transport facilities must be available for all 
pregnant women with complications at any level of health care facility (DOH, 2001:1).  
 
  4.3 HISTORY TAKING – SECTION B 
 
4.3.1  Introduction 
  
History taking is usually done by the midwife during the initial contact between the 
patient and the midwife at the level-1 health care facility. The importance of history 
taking lies in collecting all the data based on past and present experiences of the patient 
The contact enables the midwife and the patient to get to know each other and build 
rapport based on trust that can eventually develop into partnership. The activity of history 
taking forms part of antenatal care during pregnancy and focuses on information sharing 
and exchange.   
 
 
4.3.2   History on antenatal care received at level - 1 
 
As described by Fraser & Cooper (2003:251), antenatal care refers to care given to a 
pregnant woman from the confirmation of conception until the beginning of labour. 
History taking was done during antenatal care and recorded on the card known as the 
antenatal card. The antenatal card has a checklist and the following information is to be  
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obtained from the patient: 
 
 Personal data; 
 Menstrual history; 
 General health; 
 Obstetric history; 
 Medical history; 
 Family history; 
 Social history; 
 Allergies; and 
 Physical examination involving the weight, blood pressure measurement, urine 
testing and blood tests in pregnancy. 
 
To complete Section B of the data collection tool, the researcher required the above-
mentioned information to have been collected by the midwife.  
All patients were booked at various clinics in the Amatole district. A patient is considered 
to have received antenatal care if she has been seen in the antenatal clinic at least three 
times. In this study it was found that some of the patients were referred on the very first 
or second visit due to the raised BP or the presence of other signs and symptoms of PIH, 
like oedema or proteinuria. Booking of the women started at different stages of 
pregnancy, that is, the range of booking varied between 12/40 to 37/40 weeks. According 
to Fraser and Cooper (253: 2003) a booking visit is defined as the initial assessment of a  
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pregnant woman at the first visit (DOH, Eastern Cape, 4:2006). In one instance, the  
woman was booked at 37/40 weeks and two others were booked at 36/40 weeks.   
The range of antenatal visits were from 1-11. The majority of patients visited the 
natenatal clinic at least 4 times. The blood pressure recorded at booking ranged from as 
low as 100/60 to as high as 300/180 mmHg. The majority of the women experienced a 
steady increase of systolic and diastolic BP during the course of their pregnancies. 
Unbooked women were not included in the study as they were not seen by the midwife at 
a level-1 health care facility. 
 
4.3.2.1 Antenatal card 
 
There were no antenatal cards for 15.12 % (n = 44) of the patients and 84.88 % (n = 247) 
of the patients had antenatal cards in their records. Those with no antenatal cards had the 
information that was required written in their records or referral letters. Some pregnant 
women were referred from different level-1 health care facilities out of the Amatole 
district but within the Eastern Cape Province.  
 
The researcher assumed that the antenatal cards were left behind since referral letters 
contained the full information required for the study. Few antenatal cards had incomplete 
information, for example, the results of the measured BP and urine were not recorded.  
Some antenatal cards indicated the reasons for not supplying the results of the 
observations as the sphygmomanometer not working or multistix being out of stock. 
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4.3.2.2   Gravida 
 
According to Fraser and Cooper (256: 2003) gravida is defined as a pregnant woman, and 
a number refers to the number of times the woman has been pregnant regardless of the 
outcome. Primigravidae constituted 45.36 % (n = 132) of patients with PIH, followed by 
gravida 2 who comprised 28.52 % (n = 83) of the patients. The smallest number was 
gravida 6 at only 0.34 % (n = 1) among the referred patients. According to the results of 
studies that were conducted at different places, it was discovered that primigravidae also 
revealed high percentages of patients who developed eclampsia, in Peshawar 69% and in 
Quetta 58% (Shaheen, et al. 2003: Online and Ashraf, 2004: Online).  
 
Primigravida refers to a woman falling pregnant for the first time. Primigravidae are at 
risk of developing PIH because the incidence is more than twice as common in the first 
pregnancy as in multiparous women. The incidence is also higher in women over the age 
of 35 years or in elderly primigravidae where PIH could be superimposed over chronic 
hypertension. According to the second NCCEMD report for the triennium period (1999-
2001:5), maternal deaths in primigravidae were found to have increased (Fraser, Cooper 
& Nolte, 2006:242; De Kock & Van der Walt, 2004:23-5). As primigravidae are at risk of 
developing PIH regardless of their maternal age or other contributory factors like 
nutrition, social habits or socio-economic background, proper history taking at the initial 
booking visit is of vital importance. The midwife should share the information that PIH  
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recurs and is a risk factor in multigravidae with new partners (Fraser, Cooper & Nolte, 
2006:244). 
 
4.3.2.3   Parity 
 
Parity as defined by Fraser and Cooper (257:2003) refers to the number of times that the 
woman has given birth to a viable child, live or stillborn, but excluding abortions. Table 
4.5 below displays the number of times the women whose records were studied had given 
birth to a viable child or children, live or stillborn. 
 
Table 4.5: Description of parity, frequency and percentage 
 
Parity Frequency Percentage 
0 143 49.14 
1   83 28.52 
2   46 15.81 
3   13   4.47 
4     5   1.72 
5     1   0.34 
Total 291   100.00 
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Parity 0 had the highest incidence of developing pregnancy induced hypertension and 
exposure to the risk of having complications. The reason for primigravidae to be at a high  
risk of developing PIH and complications is due to a maternal immune response to foetal 
antigens derived from the father (paternal sperm) and is expressed in placental tissue. The 
prevalence decreases after long-term exposure to the paternal sperm (Fraser & Cooper, 
358:2003). 
 
4.3.2.4   Current pregnancy 
 
From the total of 291 patients with PIH, multiple pregnancy occurred in 2.15 % (n = 8) of 
patients and a singleton occurred in 97.25 % (n = 283) of patients. Multiple pregnancy, 
which was a risk factor for PIH, led to 2.15 % whilst the singleton contributed to a high 
number of women with PIH, pre-eclampsia and eclampsia. A multiple pregnancy refers 
to the condition of two or more foetuses developing in the uterus at the same time 
(Sellers, 1993: 1143). In multiple pregnancy, the growing tissues in the uterus are greater 
than normal and there is hyperplacentosis, hence the development of pre-eclampsia and 
eclampsia (Beischer, Mackay & Colditz, 262:1997). 
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4.3.3   Presence of risk factors as indicated on the antenatal card 
 
The discussion in this section focuses on the factors considered to indicate high risk to  
both the health of the mother and the foetus/es. Such factors are regarded as indicating  
high risk to the pregnant woman because they predispose the woman to the development 
of pre-eclampsia and for eclampsia. Proper history taking and screening of a pregnant 
woman are crucially important to prevent maternal morbidity and mortality and other 
complications that usually arise as a result PIH. The common risk factors that were 
identified are shown in Table 4.6.   
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Table 4.6:  Frequency and percentage of common risk factors. 
 
Risk factors 
 
Frequency 
 
Percentage (%) 
 
Hypertension before pregnancy  
12 
 
4.12 
 
Hypertension < 20 weeks 
pregnant 
 
  3 
 
1.03 
 
Hypertension in previous 
pregnancy with convulsions 
 
14 
 
4.81 
 
Previous intra-uterine death 
due to hypertension 
 
  6 
 
2.07 
 
 
Diabetes mellitus 
 
  1 
 
0.34 
 
 
Cardiac disease 
 
  4 
 
1.37 
 
 
Elderly primigravidae 
 
  7 
 
2.41 
 
Total    
 
                   35 
             
12.03 
 
 
Patients with hypertension before pregnancy were known hypertensives on medical 
treatment; the category was reported to be at risk of developing PIH. In the majority of 
cases, namely 83.84 % (n = 244) no risk factors were noted or recorded. The cause of 
PIH in those patients needed to be investigated. The records of patients without antenatal 
cards were reported earlier as making up 15.41 % (n = 44) out of 291. The information 
pertaining to the risk factors was missing and therefore could not be classified.  
112
4.3.4   Health education given on signs and symptoms of PIH to be reported 
 
The evidence showed that, out of the 291 patient sample, only 0.34% (n = 1) of 
patients were educated concerning the five danger signs to be reported as soon as 
they appeared. The information recorded on the antenatal card that was given to 
the patient by the midwife at level 1 was regarded as evidence. The rest were 
educated on routine health education topics which involved breast care, diet, 
clothing, minor disorders of pregnancy, rest, sleep, exercises and signs of labour. 
The researcher derived the information from the antenatal cards as it was recorded 
under health education given. According to the Maternal guidelines in South 
Africa, the information to be shared with the pregnant woman focuses on the five 
danger signs and symptoms to be reported to the midwife immediately they are 
noticed. As mentioned earlier on page 84.  
 
4.4   DIAGNOSIS OF PIH AT LEVEL-1 CLINICS – SECTION C 
 
In section C the researcher wished to determine whether the midwife at the level-1 clinic 
was able to make a diagnosis of PIH on the basis of the patient‟s presenting signs and 
symptoms. 
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4.4.1   Identification of signs and symptoms of PIH at level-1 clinics 
 
From the total of 291 patients in the sample, 31.96 % (n = 93) had indications of protein 
during urine testing; 46.39 % (n = 135) of the patients developed oedema of the lower 
extremities and generalised body oedema was noted in some instances, with puffiness of  
the face. Proteinuria is defined as the presence of 2+ protein in the urine on two 
occasions, measured at least four hours apart, or 300 mg protein present in a 24-hour 
specimen of urine (De Kock & Van der Walt, 2004:20-3). Normally protein molecules do  
not pass through the membranes of the Bowman capsule due to the high molecular  
weight. The increased production of thromboxane, a vasoconstrictor causing 
hypertension, is shown in increased platelet aggregation and an increased permeability of 
capillaries which contribute to reduced plasma volume and to oedema.   
 
The increased capillary permeability of kidney blood vessels allows protein molecules to 
pass through the capillaries during filtration and to be detected in urine during testing (De 
Kock & Van der Walt, 2004:20-4). A 24-hour urine collection for measuring total protein 
to provide an accurate quantitative assessment of protein loss is usually done. The 
findings are classified according to quantity of protein measured in urine. The amount of 
protein determined indicates the severity of the condition. If the findings show 300 mg in 
24 hours or more, mild to moderate pre- eclampsia is indicated, and if more than 500 mg 
in 24 hours it is considered as severe pre-eclampsia (Fraser, Cooper & Nolte, 2006:341; 
Cronje & Grobbler, 2007:498). 
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Although it was observed that generalised oedema is common in pregnancy, it may 
become more than usual in PIH due to increased capillary permeability caused by 
endothelial cell alteration and reduced intravascular volume (Beischer, Mackay & 
Colditz, 1997:208). Oedema used to be regarded as one of the positive diagnostic criteria 
 for PIH, but now it is only considered if other criteria like increased blood pressure or  
proteinuria are present. The generalised oedema that pits on pressure and is present in  
non-dependent areas like the face, lower abdomen, hands, vulva and sacral areas is 
caused by increased extracellular fluid due to damaged endothelial cells of the 
endothelium (Fraser, Cooper & Nolte, 2006:341). 
 
Systolic blood pressure that is increased by 30 mmHg early in pregnancy, that is, at less 
than 20 weeks of pregnancy, occurred in 34.02 % (n = 99) of patients while an increase in 
diastolic blood pressure by 15 mmHg was also present in 34.02 % (n = 99). During 
pregnancy, the blood pressure of the woman is expected to fall due to the effect of 
prostacyclin, a vasodilator that dominates in normal placentation so as to allow more 
blood to flow to the intervillous spaces of spiral arteries of the decidua. The process 
occurs within the 16 to 20 weeks of gestation and results in maximal placental perfusion 
(Fraser, Cooper & Nolte, 2006:338; Cronje & Grobler, 2007:500). The abnormal 
placentation resulting from a maternal immune response to foetal antigens from the 
paternal side triggers the release of one of the factors that destroy the endothelial cells, 
the factor thromboxane, a vasoconstrictor which dominates the effect of the prostacyclin 
results in hypertension, abnormal coagulation, thrombosis and increased endothelial 
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 permeability ( Fraser, Cooper & Nolte, 2006:338; Cronje & Grobbler, 2007:500).  
 
Elevated blood pressure of 140/90 mmHg on two or more occasions was present in 19.93 
% (n = 58) of patients. Blood pressure was not checked in 1.37 % (n = 4) of patients due  
to faulty equipment as recorded on the antenatal card of the patient. In some instances it  
was neither recorded nor checked and the reason was not stated.  It was observed that, 
although generalised oedema was common in normal pregnancy, in PIH it may occur 
more than usually due to increased capillary permeability caused by endothelial cell 
alteration and reduced intravascular volume (Beischer et al., 1997: 208).  In the literature 
review it was stated that a systolic blood pressure increase of more than 30 mmHg above 
the patient‟s normal blood pressure indicates raised blood pressure. Again, in Chapter 2, 
mention was made of an increase of the diastolic blood pressure by 15 mmHg above the 
patient‟s normal blood pressure denotes an abnormality. A blood pressure reading of 
140/90 mmHg or more on two occasions or more at least six hours apart indicate an 
abnormality during pregnancy (DOH, 2002:51). Based on the findings in the above 
paragraph, it is particularly true that a woman with such a blood pressure increase should 
be monitored very closely. Due to changes in the cardiovascular system during 
pregnancy, the blood pressure should be low and not increased (Nolte, 1998:290). 
According to the NCCEMD key recommendations, where it is clearly stated (in Number 
5), equipment norms should be established per level of care and such norms must be 
adhered to at every health institution concerned with the care of pregnant women (DOH,  
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2002:1). It was observed that blood pressure of some pregnant women was never checked  
due to faulty equipment (baumanometer). Blood pressure was not checked in 1.37 % (n = 
4) of patients due to faulty equipment, as recorded on the antenatal cards of the patients. 
In some instances it was neither recorded nor checked and the reason was not stated.  
 
Basic Antenatal Care (BANC) of a pregnant woman requires checking of blood pressure 
 at each antenatal visit (DOH, 2007:29; Snyder, 2002:30). It is important for the midwife 
to check the records of the previous visit at each visit so as to acquaint herself with the 
challenges identified and to assess whether challenges have been dealt with or whether 
alternate action is needed (Fraser, Cooper & Nolte, 2006:260). The midwife measures the 
blood pressure of the woman during the first visit so as to determine the baseline. During 
subsequent visits by the woman, the midwife should constantly check for a rise in systolic 
blood pressure of 30 mmHg and a diastolic rise of 15 mmHg as these indicate deviations 
from normal. One of the aims of antenatal care is for the midwife to recognise deviations 
from normal so as to prevent pregnancy from having a detrimental effect on maternal 
health. This aim can be achieved by thorough assessment of risk factors during pregnancy 
(De Kock & Van der Walt, 2004:9-2). Failure of the midwife to measure the blood 
pressure of a pregnant woman could lead to missed opportunities of identifying the 
development of abnormal blood pressure that could be detrimental to the life of the 
woman. Hypertensive diseases connected with pregnancy, for example, are classified as 
the second cause of maternal deaths, not only in SA but throughout the world (WHO,  
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2004:91). Therefore, if the blood pressure was not measured, the midwife should ask the  
pregnant woman the following questions: 
 Are there bouts of severe headache? 
 Is the vision disturbed? If yes, how is vision disturbed? 
 Is there any difficulty in breathing? 
 Are there any signs of vaginal bleeding? 
 Is the foetus moving well? When was the last time the foetus moved? Or is there a 
reduction in movements? 
 All the above questions need to be asked to exclude danger signs of pregnancy 
(Fraser, Cooper & Nolte, 2006:261). 
 
4.4.2   Presence of secondary signs and symptoms of PIH at level-1 clinics 
 
The presence of secondary signs and symptoms detected at level-1 clinics indicated the 
onset of pre-eclampsia. The observations in this regard are tabulated in Table 4.7, which 
shows the symptoms reported by patients and their frequencies and signs observed by the 
midwife. 
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Table 4.7:  Symptoms reported by patients at level - 1 and their frequency and signs   
                   observed by the midwife 
  
Sign and symptom Frequency (N= 291) 
(CNS) Severe headache   49 
Restlessness     2 
Hyperreflexia     3 
Visual disturbance     5 
Convulsions     5 
Change in behaviour     2 
Severe hypertension   14 
(CVS) Oedema 150 
Proteinuria 105 
Haematuria   13 
Upper abdominal pain   15 
Poor foetal growth     1 
Pulmonary oedema     1 
Shortness of breath     4 
Total 369 
 
The total number indicated in the above table is 369 because some patients had identified  
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more than one sign and symptom of PIH, as well as complications developing at the same 
time. One patient, for example, would present oedema, proteinuria, severe hypertension, 
visual disturbance and severe headache. The implication would be for the patient to be 
counted under severe headache and again under severe hypertension, meaning twice or 
more. 
 
The most common presenting symptoms were oedema  (n =150) severe headache (n = 
49) and upper abdominal pain (n=15). The most common presenting signs were 
proteinuria (n = 105), severe hypertension (n = 14) and haematuria (n =13). 
 
4.5    MANAGEMENT OF PIH AT LEVEL-1 CLINICS  – SECTION D 
 
As indicated in the literature, patients presenting with PIH preferably should first be 
managed at a hospital or seen by the doctor to investigate the cause. Once discharged 
from the hospital and having the blood pressure under control, they should be followed 
up and cared for by the midwife at a level-1 clinic. A woman would report for routine 
antenatal care, not knowing that she had pre-eclampsia and needed to be managed at the 
level-1 health care facility before being transferred to a tertiary hospital for further 
management of the disease by the doctor. According to the guidelines for maternal care in 
South Africa presented in the manual for clinics, community health centres and district 
hospitals, management of patients with PIH depend on the severity of the signs and 
symptoms and observations made. 
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4.5.1     Management of mild to moderate PIH by the midwife at a level-1 clinic  
  
Mild PIH, as defined in Chapter 2, is indicated by a BP reading of 140/90 mmHg or 
diastolic blood pressure of less than 100 mmHg, according to De Kock and Van der Walt 
(2004:20-7), with no proteinuria and oedema (DOH, 1998:76). 
 
Out of the sample of 291, 35.74 % (n = 104) had increased blood pressure above 120/80 
mmHg but below 160/110 mmHg, but did not have secondary signs and symptoms of 
PIH. The midwife in these instances acted according to the Maternal guidelines for the 
management of PIH in SA, in that the woman would be referred to a level-2 or -3 hospital 
on the same day (DOH, 2007:82) for further management. Patients who were started on 
antihypertensives – methyldopa 500 mg orally twice daily (DOH, 2007:84) at a level 
1facility, according to the essential drug list and Maternal guidelines for the management 
of PIH in SA, numbered 1.03 % (n = 3) patients.  
 
Of the patients who developed raised blood pressure, 1.37% (n = 4) were advised to rest 
and were reviewed within two to three days after the clinic visit; once again the Maternal 
 guidelines for the management of PIH were adhered to. According to the literature it was 
important for the midwife to refer patients with blood pressure less than 160/110 mmHg, 
even in the absence of secondary signs and symptoms, for careful monitoring during 
pregnancy and obstetrician support (Fraser, Cooper & Nolte, 2003:259). Although non- 
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proteinuric PIH rarely contributes to significant maternal morbidity and the perinatal 
mortality rate, it is recommended that careful monitoring is still essential in case 
proteinuria develops later (Beischer et al., 1998:208). 
 
4.5.1.1 Conclusion to the midwifery management of moderate PIH 
 
The midwife has an option of not referring the woman to the hospital for a BP of less 
than 160/110 mmHg, but to advise such a woman to present herself for high-risk 
antenatal care weekly, for close monitoring. Such decisions would be influenced by the 
woman‟s home circumstances. 
The midwife is supposed to inform the woman about monitoring foetal kick counts at 
home and to report abnormal patterns.  
 
4.5.2  Management of severe PIH and imminent eclampsia by the midwife at a  level-1 
clinic. 
 
Out of the total sample of 291, 28.52 % (n = 83) of pregnant women were referred to a 
tertiary hospital immediately due to the presence of the secondary signs and symptoms of 
PIH. Of these,  0.69 % (n = 2) of patients were admitted at level 1 and 2.75 % (n = 8) 
were given rapid acting drugs like nifedipine 10 mg orally at once, at level 1, to lower the 
raised blood pressure. Once again, the action taken by the midwife was found to be 
according to the Maternal guidelines for the management of PIH in SA (DOH, 2007:84). 
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In 2.06 % (n = 6) of the patients, the diastolic blood pressure was controlled to 90/100 
mmHg before being transferred to a tertiary hospital. The main aim in the management of 
severe PIH and imminent eclampsia is to stabilise the condition before referral so that 
complications do not occur en route to hospital. The midwife carried out her duties as 
recommended by Woods et al. (2006:3-28). 
 
Foetal distress was excluded in only 2.06 % (n = 6) of the patients before referral to the 
tertiary hospital by the midwife. The researcher has assumed that the Pinard stethoscope 
or doptone was used to monitor foetal condition as no electronic strips for foetal heart 
tracing were noted or attached to the antenatal card. The recommendation for foetal heart 
monitoring in such situations is the use of a CTG machine where a pattern of the foetal 
heart functioning can be seen and decisions made accordingly (DOH, 2007:82). 
 
Renal dysfunction was present in 0.69 % (n = 2) of the patients. Renal dysfunction was 
regarded as the urine output of < 500ml in 24 hours and the rapid rise of serum urea and 
creatinine levels. Serum creatinine and urea levels were the investigations done at level 3 
to assess organ dysfunction (Cronje &Grobler, 2007:503). 
  
Gestational age had been assessed in 7.22 % (n = 21) of cases. In the event that the 
gestational age was between 27 and 34 weeks, steroids were given to enhance foetal lung 
maturity. Steroids were administered to 0.69 % (n = 2) of the patients. Opinion regarding  
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transfer was sought from the referring hospital and actions were carried out as 
 recommended. It was crucial that management of severe pre-eclampsia to prevent 
complications and morbidity be done at the level-1 health facility, as not only the 
woman‟s life was as at stake, but of the foetus as well.  
Blood pressure was controlled to prevent cerebral haemorrhage and placental abruption, 
which would have led to maternal and foetal death (Beischer et al., 1998:212; Fraser et 
al., 2003:363; Nolte, 1998:298). 
 
4.5.2.1   Conclusion to midwifery management of severe PIH and imminent eclampsia 
 
 Good management of lowering or stabilising BP was noted, with concern in some 
areas;  
 Poor recording by midwives was observed; 
 
The following recommendations of the NCCEMD were not implemented:  
 Urinary output was not recorded hourly and to be tested for abnormalities; 
 Blood pressure was not measured hourly to evaluate effectiveness of administered 
medication; and 
 Indwelling urinary catheter was not inserted so as to help with the hourly 
measurement of urinary output. 
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4.5.3    Management of eclampsia by the midwife at level-1 clinics 
 
Of the 291 patients making up the total population, 1.72 % (n = 5) developed eclampsia 
at level 1. In accordance with the expected midwifery care of women with eclampsia as  
stipulated in Maternal guidelines for the management of PIH in SA (DOH, 2007:84) the  
following was done: 
 One of the five patients was turned to the left lateral position to promote good 
oxygenation to the foetus and to prevent supine hypotensive syndrome; 
 Two of the five patients had their airways cleared, after which insertion of the 
oropharyngeal airway was done to facilitate air entry to the lungs;  
 Ringers lactate solution was given intravenously to all five patients; the amount 
administered and over how many minutes it was run was not stipulated;    
 Blood pressure was monitored quarter-hourly in all five patients until stabilised 
between 90/100 mmHg before transferring the patient to the tertiary hospital; 
 Magnesium sulphate was administered as loading and maintenance doses to one 
of the five patients and was continued during the transfer to a tertiary hospital; 
 Foley‟s indwelling catheter was inserted in one of the five patients to monitor 
urinary output hourly.  
 
Monitoring the urinary output and urinalysis 4-hourly for ketones, glucose and protein are 
important for detecting the extent of renal damage. The presence of protein indicated  
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reduced kidney perfusion, reduced creatinine clearance, increased serum uric acid and  
creatinine. The output of 30 ml/hour reflected adequate renal function, but any output 
below 30ml/hr should have been reported to the doctor immediately (Fraser & Cooper, 
2003:363; Nolte, 1998:299). 
 
4.5.3.1 Conclusion to the management of eclampsia 
 
The following recommended actions were omitted: 
 Oxygen was not administered to the woman though convulsions led to poor 
placental perfusion; 
 No cot sides or other precautionary measures were taken by midwives to prevent 
injuries to the woman; 
 No monitoring was recorded of fluid given to the mother so as to prevent 
pulmonary oedema and fluid overload; 
 No recording of precautionary measures that were supposed to be taken before 
MgSo4 was administered. The precautionary measures are required to prevent the 
detrimental effects of the drug to the woman. 
 
The researcher noted that all the recommendations in Maternal guidelines for the 
management of PIH were not followed by the midwife at the level-1 clinic. 
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4.6   PRESENCE OF THE REFERRING CRITERIA OF PIH AT LEVEL-1   
        CLINICS – SECTION E 
 
Complications that developed at level 1 which compelled the midwife to refer the patient 
are shown in Table 4.8. The total number of complications recorded was 293, as some 
patients developed more than one complications. 
 
Table: 4.8   Complications of PIH at level-1 clinics 
 
 
Criteria 
 
Frequency 
 
Percentage (%) 
Antepartum haemorrhage     7    2.41 
Abnormal liver function test 126  43.30 
Coagulation deficiency   23    7.90 
Lung oedema     5    1.72 
Renal dysfunction 121  41.58 
Prematurity   11     3.78 
Total 293 100.00 
 
Antepartum haemorrhage is a complication that occurs as a result of placental abruption,  
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which is premature separation of a normally situated placenta occurring after 22 weeks of  
pregnancy (Fraser & Cooper, 2003:302). Placental abruption occurs as a result of sudden 
reduction in the size of the uterus, as in the case of the preterm prelabour rupture of 
membranes. 
 
 Abnormal liver function tests resulting from sub capsular hepatic syndrome are due to 
reduced hepatic flow and hepatic haemorrhage because of the swelling of the liver. 
 
Coagulation deficiency results from damage to tissues at the placental site, causing large 
quantities of thromboplastin to be released into the circulation due to break-down in 
platelets (Fraser & Cooper, 2003:30 
 Lung or pulmonary oedema is caused by oedema within the intracellular space, resulting 
from capillary permeability due to damaged endothelial cells. 
 
Renal dysfunction results from decreased renal blood flow producing hypoxia and 
oedema of the endothelial cells of the glomerular capillaries. Damage of the glomerular 
endothelium allows plasma protein to filter into the urine, producing proteinuria. Oliguria 
develops as the condition worsens, due to kidney damage. Renal damage is reflected by 
increased serum creatinine, uric acid levels and reduced creatinine clearance. 
 
Prematurity is caused by placental abruption leading to placental insufficiency and  
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hypoxia, so that, to save the foetus, birth has to take place whether by induction or  
caesarean section. 
 
The majority of the investigations undertaken to assess the extent of the dysfunction of 
organs were done at the tertiary hospital, on admission. This finding was not unexpected, 
as further investigation of a patient with PIH and eclampsia should ideally be done at the 
tertiary level as opposed to the primary level. However, blood investigation of patients 
with PIH and eclampsia was done at a few of the level-1 clinics. The researcher assumed 
that, if the investigations undertaken on arrival of the patient at a tertiary hospital 
revealed abnormalities, the abnormalities would have been present at the level-1 facility, 
but there was no laboratory service to investigate the patient. 
 
 
4.7   CONCLUSION 
 
Although the Eastern Cape has six districts and one metropolitan area, patients from five 
districts only were referred to the East London Frere Hospital, a tertiary institution. The 
age of patients ranged from as young as 14 to as old as 46 years, and parity was from 0 to 
5. Primigravidae constituted the majority of pregnant women. There were women who 
referred themselves to the tertiary hospital whose signs and symptoms of PIH were 
identified at level 3 while missed by the midwife at level 1. The reasons for their self- 
referral were revealed through complaints such as the following: 
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 No foetal movements felt; 
 Labour pains; 
 Vaginal bleeding; 
 Epigastric pain; 
 Blurred vision; and  
 Convulsions. 
 
Booking of pregnant women started from as early as the 12th week and ranged to as late 
as the 37th week of pregnancy. During history taking, the following risk factors that 
occurred with previous pregnancies were identified: 
 
 Intra-uterine death; 
 Diabetes mellitus; 
 Hypertension with convulsions; 
 Hypertension before pregnancy; 
 Hypertension developing in less than 20 weeks of pregnancy; 
 Cardiac problems; and 
 Elderly primigravida. 
 
Eight (2.15 %) of the pregnancies were multiple pregnancies and 97.25 % (n = 283) were 
singletons. Pregnancy-induced hypertension as a risk factor occurred more in singleton 
pregnancies versus multiple pregnancies. 
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During observations, BP as low as 100/60 mmHg to as high as 300/180 mmHg were  
measured, and proteinuria 4+ and oedema 3+ were noted. In some instances the BP was  
not measured due to a faulty baumanometer and urine was not tested to exclude the 
presence of protein due to multistix being out of stock. This was a risk, as abnormalities 
could not be detected. 
 
Health education given by the midwives was not specific with regard to the danger signs 
of pregnancy; only one patient had recorded evidence indicating that she was informed 
about the danger signs of pregnancy.  The remaining 99.66 % (n = 290) of patients had 
recorded evidence of being educated concerning minor disorders of pregnancy and 
routine issues like clothing, diet, etc.  
 
Regarding the management of PIH by the midwife at level 1, the Maternal guidelines for 
the management of PIH in SA, were not well followed or implemented, as: 
 
 The patients with a blood pressure increase of more than 30 mmHg systolic and 
15 mmHg diastolic after 20 weeks of pregnancy were not noted and followed up. 
 Urine in patients whose blood pressure had increased from the normal after 20 
weeks were not tested to exclude the presence of protein in their urine.   
 No transport was arranged to ensure the safety of the referred patients who had 
increased blood pressure. 
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The complications that compelled midwives to refer to level 3 included:  
 
 Antepartum haemorrhage; 
 Coagulation deficiency; 
 Prematurity; 
 Lung oedema; and 
 Abnormal liver function. 
 
Poor recording was noted with concern, as this revealed the quality of midwifery care 
rendered to the pregnant women.  
 
Transport was noted to be a challenge when women had to be referred to a higher level of 
care for further management.    
 
The conclusion summing up the whole chapter‟s findings, together with 
recommendations for practice and further research discussed in detail in Chapter 5.  
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CHAPTER 5 
 
CONCLUSION, RECOMMENDATIONS AND LIMITATIONS 
 
5.1   INTRODUCTION  
 
The conclusions arrived at according to the findings of analysed data, and 
recommendations for future practice and midwifery research are presented in this chapter. 
 
5.2    CONCLUSION 
 
5.2.1 Region / District 
 
The Eastern Cape Province is composed of six districts and one Metropole. Five of the 
six districts referred patients to Frere Hospital, the Amatole district tertiary hospital at, 
the East London complex. Alfred Nzo, the Amatole clinics and the secondary hospitals, 
namely O.R. Tambo, U-Khahlamba and Chris Hani, also referred patients to the tertiary 
hospital in the Amatole district, although the numbers were very small: out of the total 
population of 291 in the study, only 7.56 % (n = 22) patients were received. The reason 
for the referral for further management of PIH was that some of the regional and district 
hospitals did not have anaesthetists for a caesarean section to be performed and had no  
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laboratory services for investigations to assess the extent to which organs like kidneys, 
liver and blood tissue had been affected. 
 
5.2.2 Age 
 
The ages of pregnant women ranged from 14 to 46 years. As the child bearing age in 
South Africa is regarded as from 15 to 49 years, age did not present a challenge. 
 
Out of the sample of 291, only one (0.34 %) pregnant woman was 14 years old and a 
primigravida below the reproductive age, which, according to the National Maternal 
Guidelines in SA, start at 15 years of age. Early reproductive age is a risk factor for PIH.          
                        
5.2.3 Referrals 
 
Referral of pregnant women in this study involves sending women from a level-1 facility 
to a tertiary hospital for further management of PIH by the doctor. The research has 
indicated that the referral system to be followed was not well understood by the 
midwives, more especially those working in clinics around the Amatole district, as 
patients were left to fend for themselves with regard to how to get to the tertiary hospital 
when referred. On two occasions, patients with a blood pressure of 140/90 mmHg, whose 
diastolic pressure continued to rise (by 15 mmHg) from baseline diastolic blood pressure  
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were either not considered as no action was taken by the midwife. Of the participants in 
 the study, made up from the 291 patients records that were reviewed, 83.16 % (n = 242) 
were referred to tertiary hospital by the midwife. The remaining pregnant women 
comprising 16.84 % (n = 49) referred themselves to a tertiary hospital due to a reduction 
in foetal movements, blurred vision, labour pains, epigastric pain, convulsions or per 
vaginal bleeding. The latter category was missed by the midwife at level 1, as signs and 
symptoms of PIH were only noted on admission at the tertiary facility. The referred 
women were mainly from different clinics, day hospitals and health care centres in the 
Amatole district, which has one hundred and sixty nine (169) clinics in total. 
 
5.2.4 Transport 
 
Transport used for conveying patients to the tertiary hospital was not safe as no health 
care provider was available during transportation. In the case of 66.66 % (n = 194) of the 
patients, the mode of transport was either not known, or private or public. Maternal 
patients are supposed to be transported by ambulance when referred to a tertiary hospital 
and to b accompanied by a midwife, doctor or skilled paramedic for the monitoring of 
blood pressure and foetal condition on the way to hospital, to prevent complications like 
eclampsia and permanent kidney damage.  
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5.2.5 Antenatal care and antenatal card 
 
The records revealed that patients were booking in at various times during their 
pregnancies and some were prompted by the onset of signs and symptoms of PIH.  
Antenatal cards were not presented for 15.12 % (n = 44) of the patients, which could be 
attributed to the loose documents that were used or to being left behind in referring health 
care centres. The time recommended for  booking was as soon as the woman realised that 
she was pregnant, as early antenatal booking is important for the woman who has 
hypertension or experienced complications related to PIH in a previous pregnancy, or has 
used an IUD. Antenatal booking should start as soon as a woman realises that she is 
pregnant, at the least at three months (Nolte, 1998:77; Fraser et al., 2003:254). All the 
patients whose records were investigated for the study had booked at a level-1 clinic; no 
patients booked at the tertiary hospital. 
 
5.2.6  Gravida 
 
Out of the total sample of 291, 45.36 % (n = 132) patients were primigravidae and 5.30 % 
(n = 7) of those who had fallen pregnant for the first time were older than 35 years. 
Primigravidae, more especially elderly primigravidae, are at an increased risk of 
developing PIH, as explained in Chapter 4.   
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5.2.7 Current pregnancy 
 
Singleton pregnancies occurred in 97.25 % (n = 283) of the women who developed PIH, 
pre-eclampsia and, in few cases, eclampsia, while pregnant women with a multiple 
pregnancy are at an increased risk of developing PIH, refer to precipitating and risk 
factors on page 50.  
 
5.2.8   Presence of risk factors as indicated on the antenatal card 
 
Risk factors were identified in some patients who developed PIH. One potential risk 
factor was HIV; 24.05 % (n = 70) of the pregnant women who developed PIH were also 
diagnosed as being HIV positive. HIV/AIDS could have had some effect on the blood 
pressures of the pregnant women, but the pathophysiology of the disease needs further 
investigation and understanding. (Fraser, Cooper & Noite, 2006:339)
 
5.2.9   Health education given on signs and symptoms to be reported 
 
When she attends the antenatal care facility, a pregnant woman is given health education 
according to identified need/s and education on the danger signs and symptoms of PIH to 
be reported are supposed to be given to prevent maternal mortality and morbidity due to 
this condition. The signs and symptoms that are dangerous with regard to pregnancy are  
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explained in Chapter 2. The records on health education, however, did not reveal that  
these signs and symptoms were shared with women, except in one case (0.34 %). For 
most of the pregnant women, there was no record indicating that they had been made 
aware of the danger signs and symptoms of PIH that had to be reported immediately 
when they occurred or that they had been warned not to wait for the next appointment 
date to make mention of it.   
 
5.2.10   Identification of secondary signs and symptoms of PIH at level-1 clinics 
 
There was poor identification and diagnosis of PIH: 16.80 % (n = 49) of the patients had 
been overlooked by the midwife at the level-1 clinic.  
 
5.2.11   Management of mild, moderate and severe PIH, imminent eclampsia and 
eclampsia  
 
Management of patients who developed pre-eclampsia and eclampsia was poorly done by 
the midwife as there were hardly any records concerning measurement of BP and testing 
of urinary output, except for 0.69% (n = 2) of the patients and only 0.34 % (n = 1) had 
had an indwelling catheter inserted. 
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Monitoring of foetal growth by means of symphysis fundus height (SFH) measurement 
was not done, as this was noted for only 0.34 % (n = 1) of the patients.  Foetal distress 
was excluded in 2.06 % (n = 6) of the patients out of the 291 patients seen at level 1; this 
action did not reflect safe midwifery practice as 97.93 % (n = 285) of the patients were 
not assessed for foetal wellbeing. Foetal distress was to be excluded by listening to the 
foetal heart rate using either the foetoscope, doptone or CTG and monitoring the foetal 
movements by asking the mother about foetal activity. 
 
 
5.3   RECOMMENDATIONS 
 
5.3.1  Introduction 
 
The researcher identified various gaps in the midwifery care and management of the 
pregnant woman with PIH at level 1. The gaps identified were classified as avoidable, as 
opportunities to recognise the signs and symptoms of PIH at level 1 were missed by the 
midwife and substandard care was provided. The researcher could not understand why 
there was a problem with arranging transport for referred pregnant women to the next 
level of care no reason for it was recorded anywhere on the patients‟ antenatal cards.  
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Pregnancy-induced hypertension is the second cause of maternal death in South Africa, as 
in other countries, and it is therefore imperative for the midwife to be able to manage the  
pregnant woman with PIH. The recommendations for effective management and care of a 
pregnant woman with PIH at level-1 facilities will be discussed in the following 
paragraphs.  
 
 Refer the patient with PIH on the same day the diagnosis is made 
 
It is recommended that midwives at level-1 clinics should not only consider increased 
blood pressure, that is, the systolic and diastolic blood pressure, only, but should also 
consider the normal blood pressure of the individual woman, if known, and look for the 
30 mmHg increase in the systolic blood pressure and the 15 mmHg increase of the 
diastolic blood pressure (De Kock & Van der Walt, 2004:20-30). 
 
A woman with PIH should be referred to hospital and transported from level 1 on the 
same day (DOH, 2007:81). The midwife is responsible for arranging transport to the 
referral hospital and for handing over the patient to the doctor and the referral hospital 
telephonically. In the case of severe PIH, imminent eclampsia and eclampsia, the 
receiving hospital should be informed so that they can prepare to receive the patient 
(DOH, 2007:81).  
 
 
140
 Provide health education and list the danger signs on the antenatal card 
 
Education should be given to encourage women to start attending antenatal clinics early 
when pregnant to obtain a baseline blood pressure, at the latest at three months, to 
monitor both maternal and foetal conditions and to diagnose abnormalities before 
complications become life-threatening emergencies (WHO, 1998: 21) 
 
If the clinic is accessible patients are more likely to attend early and prevent 
complications (WHO, 1998:63).  
 
Women should be encouraged to attend antenatal care clinics regularly; it was noted that 
the return dates were ignored by the patients in some cases. One of the independent 
functions of the midwife is to provide information to pregnant women (DOH, 2007:19). 
According to safe motherhood practices, antenatal care sessions should be used as an 
opportunity to provide information to women and their families about danger signs and 
symptoms. Provision of the information should help them to plan the delivery on the 
basis of the woman‟s history and the status of her health (WHO, 1998:22). 
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 Ensure all documents are present when referring patients with PIH 
 
When referred, the antenatal cards of the pregnant women should be included in the 
documents that are sent with the patient to the tertiary hospital and not be left behind in  
the folder, as valuable information can be obtained from it. Every pregnant woman 
presenting at a health care facility should be given an antenatal card. The antenatal card is 
the principal record of the pregnancy and must be completed by the midwife on each and 
every visit. The woman should keep the antenatal card and present it whenever she 
presents herself at a health facility until delivery, after which it will be kept at the place of 
birth (DOH, 2007:19). On admission to antenatal care, a proper history of the woman 
should be recorded as most of the gaps on the cards were noted in connection with 
incomplete histories. Full and proper history taking refers to the current pregnancy, 
allergies, familial and genetic disorders, present medical history, use of medication, 
alcohol and other substances, family and social circumstances, present and past obstetric 
history, surgical, social, gynaecological and general history recording necessary personal 
data (DOH, 2007:20; Fraser & Cooper, 2003:360).  
 
 Prevent advanced maternal age and early primigravida through effective 
contraception 
 
Women who have completed their families should be encouraged to be sterilised or to use 
an effective means of contraception to avoid unwanted pregnancies and related  
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complications. The midwife must ensure access to information on contraception;  
provision of service is the key element of the Mother-Baby Package (WHO, 1998:19). 
Although any pregnancy carries some risk of maternal death or morbidity, some are more 
risky than others, for example, very young women, women of high parity and older 
women. Contraception also helps to prevent unwanted pregnancies as these are a threat to 
the woman‟s health because she may resort to unsafe abortion with all its risks (WHO, 
1998:19). There are several strategies that can be used by the midwife, which include 
health education of adolescent boys and girls on issues related to reproduction, human 
sexuality and the inadvisability of early marriage and pregnancy (WHO, 1998:20). 
Contraception is one of the five pillars of safe motherhood in South Africa which is 
provided to ensure that individuals and couples have the necessary information so as to 
plan the timing, number and spacing of their pregnancies (DOH, 2007: 8).  
 
Women who had severe PIH when pregnant should be encouraged to start antenatal care 
as soon as they suspect that they are pregnant again. Proper health education should be 
given regarding PIH in future pregnancies; the partner should be involved as well (Fraser 
et al., 2003:257). 
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 Provide enough staff for the level-1 clinics 
      
There should be adequate staffing, determined according to the staff establishment of the  
particular facility. Advanced midwives, midwives, enrolled nurses, nursing assistants, a 
community health worker and a visiting or resident medical officer should be available 
(DOH, 2007:13). 
 
Midwives should educate each and every pregnant woman about the danger signs and 
symptoms which could indicate the onset of PIH and should to be observed and reported; 
to save time, such teaching could be done in a group rather than on individual basis. The 
researcher assumed that one of the contributory factors to not providing health education 
may have been due to staff shortages. Staff shortage should not compromise the quality 
of care that the pregnant woman should receive.  
 
 Train midwives on the management of PIH at level 1 
 
According to Snyder (2002:49), a midwife is defined as a skilled attendant who has been 
trained to be proficient in the skills necessary to manage normal deliveries and diagnose 
and refer complications. Ideally, the skilled attendant should be a person who lives in and 
is part of the community that is served. Midwives should be able to manage normal 
labour and delivery, identify the onset of complications, perform essential interventions,  
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start treatment and supervise the referral of both mother and baby for interventions that  
are beyond their competence or not possible in the particular situation. The skilled 
attendants should work in collaboration with traditional birth attendants for deeper 
penetration into the communities (Cronje & Grobbler, 2006:679). A programme for the 
continuing education of staff is essential; in the Western Province, the following are 
provided: 
 
 Orientation courses for new personnel on the guidelines for PIH; 
 Perinatal mortality and morbidity meetings held at least once a month where PIH 
as a cause of death is specifically discussed; 
 Feedback on patients referred to hospital to reveal whether the referral was 
appropriate or not in cases where the patient has been identified as a being at high 
risk for developing PIH and the need to attend a high risk antenatal care at a level 
3 institution; 
 Case discussions in which patients in the antenatal clinic, labour and postnatal 
wards are included to empower them on foetal movement monitoring or kick 
counts at home and what other danger signs to look for. A patient in labour has a 
partogram to be scrutinised for any rise in blood pressure or presence of protein in 
urine. 
 Refresher courses which should focus on routine procedures and advanced 
techniques; and 
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 Outreach programmes for promoting team spirit and support to implement the  
National Guidelines for Maternity care. 
  
Midwives should be technically competent and this competence depends on regular 
training and retraining and being able to access and implement guidelines for clinical 
treatment in order to provide quality care. The person with midwifery skills should be the 
key provider for the implementation of interventions (WHO, 1998:59). In order to 
develop and manage human resources, the specific skills to improve maternal health care 
will depend on national and local needs. The managers and direct care providers should 
be appropriately trained and supported by the clinical skills and supervisory capabilities 
of staff. The upgrading of midwifery skills should be treated as a priority where 
assessment of the needs for training and retraining of maternal health care managers and 
providers are done (WHO, 1998:58). Midwives should take responsibility for the full 
range of women‟s reproductive health needs, including the management of life-
threatening conditions (WHO, 1998:15).  
 
 Magnesium sulphate protocol 
 
The midwife should familiarise herself with the loading and maintenance doses of 
MgSO4 to be used whilst awaiting referral as well as the safe administration of fast acting  
drugs for lowering BP (DOH, 2007:86). 
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 Foetal condition 
 
Assessment of the gestational age and foetal condition should be done at level 1, 
irrespective of whether the patient is being referred or not, as that is the recommendation 
and is in line with the regulations governing the actions of the registered midwife (Cronje 
& Grobbler 2006:507), and as stipulated in R2488 and R2598. 
 
 Observations 
  
A specimen of urine should be tested for proteinuria at each and every visit and results 
must be recorded; the same applies to the measurement of the blood pressure to identify 
and manage hypertension (Snyder, 2002:30). 
 
 Equipment 
 
The resuscitation equipment should be checked at regular intervals so as to ensure that it 
is in working order and, if faulty, should be sent for repairs. Ordering of stock needs to be 
done on time. A monthly inventory of available stock should be done and a record kept. 
The minimum package of care for a pregnant woman can only be fulfilled if all the 
investigations and observations are done as recommended at each and every visit to the 
antenatal care clinic. There should be functioning blood pressure apparatus and cuffs of  
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different sizes, stethoscopes and urine dipsticks for urine testing (DOH, 2007:169; Fraser, 
Cooper & Nolte, 2006:247; WHO, 1998:61).  
 
 Records 
 
Records should be completed and kept safe as that is the SANC requirement and no 
document should be missing in case the record is required for either an investigation or a 
hearing. There should be a record auditing committee appointed to ensure that the quality 
of care given to pregnant women is of high standard (DOH, 2007:19). In-service 
education for midwives should be planned and conducted with particular reference to PIH 
whenever there are new updates and developments. The Provincial and District Mother, 
Child and Women‟s Health (MCWH) services should make it a point that the reports and 
recommendations made by the NCCEMD after each triennial report are made available to 
all level-1 clinics for implementation.  The supervisors of the level-1 clinics should 
monitor the implementation of the National Guidelines for Maternal Care whenever the 
midwife is managing pregnant women (WHO, 1998:65). 
 
 Continuing  education 
  
The level-1 clinics should be staffed adequately so that the midwives can attend 
workshops, midwifery congresses and seminars to keep them up to date with the latest  
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developments (Cronje & Grobbler, 2006:679; Snyder, 2002:28). The researcher also  
noted that the terms which are used are the old terms that are not used anymore, like 
intra-uterine growth retardation instead of intra-uterine growth restriction (Cronje & 
Grobbler, 2006:739). 
 
5.4   LIMITATIONS OF THE STUDY 
 
The following were identified as the limitations of this study: 
 The records of patients had incomplete notes, which made data analysis difficult 
as information was missing. 
 Unbooked patients who presented themselves at the tertiary hospital could not be 
included in the study as they were not seen by the midwife at a level-1 health care 
facility and did not have antenatal cards. 
 Patients who referred themselves to the tertiary hospital did not have the 
necessary documentation from the clinic and safe transport services for both 
maternal and foetal conditions could not be included in the study either. 
 Patients who died at level 1 prior to referral or during the referral process were not   
included in the study; 
 Patients who died at home were not included in the study;  
 Patients who developed post partum PIH were not included in the study; and 
 Some patients may have had transport arranged but did not use this transport.                                                                                                                                       
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5.5   CONCLUSION 
 
The researcher has described the extent to which the national guidelines were 
implemented at level 1 in the management of the woman with PIH. Given the findings of 
study, the researcher has made recommendations with the intention of reducing mortality 
due to PIH in the Eastern Cape. These recommendations will be distributed to the 
Department of Health, Maternal Child and Women‟s Health Director, Lilitha College of 
Nursing and District Health Services. 
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